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ABSTRACT 
 
Bioprinted Superparamagnetic Nanoparticles for Tissue Engineering Applications: 
Synthesis, Cytotoxicity Assessment, Novel Hybrid Printing System 
Kivilcim Buyukhatipoglu 
 
 
 
 
Novel technologies are required in tissue engineering to manufacture three-dimensional 
organs with complex architecture. While superparamagnetic nanoparticles have been widely 
used in medicine for magnetic resonance imaging and targeted drug delivery, they have not been 
extensively applied in tissue engineering. These nanoparticles would allow active patterning and 
non-destructive imaging during tissue growth and development. However, no inexpensive 
method exists for synthesis of commercial amounts of these nanoparticles with controlled 
morphology, chemistry and size. Furthermore, superparamagnetic nanoparticle cytotoxicity 
mechanisms are not well understood, which makes it difficult to control or block adverse 
nanoparticle effects on human health. 
In this dissertation, superparamagnetic iron oxide nanoparticles were produced by flame 
synthesis using a coflow diffusion flame. Nanoparticle flame synthesis has significant 
advantages, including improved nanoparticle property control and commercial production rate 
capability with minimal post-processing. Final iron oxide nanoparticle morphology, elemental 
composition, and particle size was controlled by changing flame configuration, flame 
temperature, and additive loading, and morphology, elemental composition, and particle size of 
the synthesized nanoparticles were analyzed by electron microscopy (TEM, ESEM, EDS), and 
Raman Spectroscopy. Then flame synthesized iron oxide nanoparticle interaction with 
xvi 
 
 
endothelial cells was compared to commercially available iron oxide nanoparticles. Flame 
synthesized particles showed no statistically significant toxicity difference from commercially 
available nanoparticles, as measured by Live/Dead assay, Alamar blue, and lactase 
dehydrogenase release. Both synthesized and purchased nanoparticles localized inside the cell 
cytoplasm as shown by TEM images. Iron oxide nanoparticles resulted in an increase in reactive 
oxygen species (ROS) formation in cells within the first three hours after nanoparticle uptake, 
and this ROS formation contributed to actin cytoskeleton disruption. Finally, a new hybrid nano-
bioprinting technique that facilitates manipulation and tracking of cells and bioactive factors 
within a three-dimensional tissue construct was developed. This technique combined the initial 
patterning capabilities of syringe-based cell deposition with the active patterning capabilities of 
superparamagnetic nanoparticles. Superparamagnetic iron oxide nanoparticles, either in the 
alginate biopolymer or loaded inside endothelial cells, were bioprinted using the hybrid solid 
freeform fabrication direct cell writing system and they were manipulated using an external 
magnet and imaged by MicroCT.  
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CHAPTER I: INTRODUCTION 
 
 
1.1 Thesis overview 
Nanoparticles are of great scientific interest as they are effectively a bridge 
between bulk materials and atomic or molecular structures. The magnetic, chemical, 
mechanical, optical and electrical properties of materials change as their size approaches 
the nanoscale and as the percentage of atoms at the material surface becomes significant. 
Recent developments in nanotechnology allow us to produce, characterize and change 
functional properties of nanoparticles for use in catalysts [1], gas sensors [2], optical 
magnetic recording [3] and various biomedical applications including magnetic 
resonance imaging (MRI), hyperthermic treatment for malignant cells, targeted drug and 
gene delivery, and magnetic cell separation[4]. With the availability of these new 
applications, new techniques should be developed to scale the processes to commercially 
accepted levels at the same time develop lower cost approaches to nanoparticle synthesis. 
Many experts worry, however, that the unique properties of these particles could 
make them toxic, and fear over the potential dangers of nanoparticles has led to 
increasing calls for tests and regulations. To decrease the potential health risks, 
nanoparticle toxicity and molecular mechanisms triggered when particles come into 
contact with living cells should be investigated. By testing engineered particles on cell 
cultures, researchers could identify those particles that are most likely to be dangerous.  
Recent studies have enabled the use of nanoparticles in medicine to unlock new 
frontiers in diagnosing, treating, and preventing disease; relieving pain; and preserving 
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and improving human health. In the relatively near term, nanomedicine can address many 
important medical problems by using nanoscale-structured materials and simple 
nanodevices that can be manufactured today. Among other bioapplications, 
nanotechnology has potential to create revolutionary products in regenerative medicine 
and tissue engineering. There will be a big demand for nanoparticles and nanostructures 
in tissue engineering, especially in areas such as cell therapy and organ regeneration. 
Nanoparticles can provide the controlled release of bioregulating signals to tissue 
scaffold material, can modify material transport properties, or can be used to manipulate 
cells and bioactive factors in three dimensional tissue scaffolds. 
In support of these concepts, this thesis consists of a series of studies to develop a 
new technique to synthesize superparamagnetic iron oxide nanoparticles in an easy to 
scale up and affordable method, to investigate the toxic effects and toxicity mechanisms 
when nanoparticles interact with cells, and finally to explore possible unique applications 
of the synthesized nanoparticles in tissue engineering. The specific aims of this work are: 
• Chapter 2: Develop a novel flame synthesis system to synthesize 
superparamagnetic iron oxide nanoparticles with controlled size and 
morphology. 
• Chapter 3: Determine if flame synthesized nanoparticles are equally 
biocompatible as commercially available nanoparticles, and clarify the 
underlying nanoparticle toxicity mechanisms in cells. 
• Chapter 4: Develop a novel hybrid bioprinting system which combines the 
initial patterning capabilities of syringe-based cell deposition with the 
3 
 
 
active patterning capabilities of superparamagnetic nanoparticles to 
facilitate manipulation and tracking of cells and bioactive factors within a 
three-dimensional tissue constructs. 
This thesis advances knowledge in nanoparticle flame system by introducing a 
unique technique to synthesize bulk iron oxide nanoparticles in a cheap and easy to scale 
up process. Our research further defines flame synthesis parameters that control the size 
and chemistry of the synthesized nanoparticles. It also clarified the major toxicity 
mechanisms that trigger cell death in magnetically labeled nanoparticles, reactive oxygen 
species formation and actin cytoskeleton disruption. The newly developed hybrid solid 
freeform fabrication technique could dramatically enhance our understanding of organ 
development and our ability to fabricate organs in vitro by allowing tracking and 
manipulation of cells and bioactive factors within the tissue engineering construct.  
 
1.2 Superparamagnetic Nanoparticles 
1.2.1 Nanoparticles 
A particle having one or more dimensions of the order of 100 nm or less is called 
a nanoparticle. Extensive nanoparticle libraries, composed of an assortment of different 
sizes, shapes, and materials, and with various chemical and surface properties, have 
already been constructed. Carbon nanotubes, liposomes, nanoshells, dendrimers, quantum 
dots, spherical nanoparticles, and nanorods can be counted as main classes of the existing 
nanoparticles [5]. Nanoparticles are of great scientific interest since they form a bridge 
between bulk materials and molecular structures.  Material properties change as material 
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size approaches the nanoscale and the percentage of atoms at the material surface 
becomes significant. While the percentage of surface atoms in bulk materials larger than 
one micrometer is microscopic relative to the total atom number, the material surface 
dominates bulk properties in nanoparticles. 
 
1.2.2 Unique Properties of Nanoparticles 
Nanoparticle size confers unique, size-dependent properties such as surface 
plasmon resonance in some metal particles [6], quantum confinement in semiconductor 
particles [7] and superparamagnetism in magnetic materials [8]. Copper nanoparticles 
smaller than 50 nm are super hard compared to bulk copper, and they do not exhibit the 
same flexibility and ductility [5]. This material property change occurs because bulk 
copper bending occurs with copper atoms/cluster movement at about the 50 nm scale. 
When nanoparticles are smaller than 50 nm, there are no clusters to bend. The quantum 
confinement effect can be observed once the semiconductor nanoparticle diameter is of 
the magnitude as the wavelength of electron wave function [9]. Quantum confinement 
describes how the electronic properties, in other words the organization of energy levels 
into which electrons can climb or fall, and optical properties change when the material 
sampled is 10 nanometers or less. When nanoparticles are small enough to restrict their 
electrons and produce quantum effects, they often have unexpected visual properties like 
gold nanoparticles appearing red in solution. Reactions take place at the surface of a 
chemical or material; the greater the surface for the same volume, the greater the 
reactivity. Since nanoparticles have very high surface area to volume ratio, they are 
5 
 
 
highly reactive. One prime example of surface area to volume ratio at the nanoscale is 
gold nanoparticles. At the macroscale, gold is an inert element, meaning it does not react 
with many chemicals. At the nanoscale, gold nanoparticles become extremely reactive 
and can be used as catalysts to speed up reactions [10]. 
 
1.2.3 Superparamagnetism 
A unique property of nanoparticles observed only in the nanoscale is 
superparamagnetism in magnetic materials. Below approximately 15 nm, particles do not 
show any ferromagnetic behavior, which means particles do not show any permanent 
magnetization after the external magnetic field is removed. However, they still exhibit 
strong paramagnetic properties with a very large susceptibility (the degree of 
magnetization in a substance in response to an applied magnetic field).  
Nanoparticles are superparamagnetic rather than ferromagnetic due to the of 
electron spin alignment under the applied magnetic field. Ferromagnetic particles have 
unpaired electron spins, which align themselves spontaneously. For this reason, these 
materials exhibit magnetization without being in a magnetic field. Ferromagnetic 
particles also exhibit permanent magnetization when they are removed from the magnetic 
field.  When the field direction is swapped, ferromagnetic materials initially oppose the 
field change but eventually most domains switches their magnetization vectors and the 
same inverse magnetization is accomplished. When ferromagnetic materials reach 
particle dimensions smaller than a particular domain, they are no longer ferromagnetic 
and are called superparamagnetic [11]. In the case of paramagnetic particles, a magnetic 
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field is altered by the magnetic materials present in it. If a particle contains magnetic 
moments that can be aligned in an external magnetic field, this will amplify the field. 
Such substances exhibit the property of paramagnetism. In contrast to ferromagnetic 
materials, paramagnetic materials do not exhibit any permanent magnetization when they 
are removed from the magnetic field. In paramagnetic materials, permanent atomic 
magnetic moments can be reoriented in an external field. Orbiting electrons or atomic 
nuclei are the source of these magnetic moments. When an external magnetic field 
applies torque to these moments they orient parallel to the field [12]. 
Superparamagnetism enables nanoparticle stability and dispersion upon magnetic 
field removal, as no residual magnetic force exists between the particles. Apart from the 
application areas of superparamagnetic nanoparticles in medicine, which will be 
described later in detail, they are used as ferrofluids in industry to form liquid seals 
around the spinning drive shafts in hard disks, to reduce friction, and to remove heat from 
the voice coil in loudspeakers [13].  
 
1.3 Superparamagnetic Nanoparticle Synthesis  
Nanoparticle synthesis methods can be varied to improve control over particle 
size, distribution and morphology to synthesize cheaper nanoparticles with enhanced 
functionality. The superparamagnetic nanoparticles widely in medicine are commonly 
synthesized using two methods: liquid phase synthesis and gas phase synthesis. Liquid 
phase synthesis methods include sol-gel processing, coprecipitation, inverse 
microemulsions and polymer matrix-mediated synthesis. Gas phase synthesis methods 
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include laser ablation, plasma synthesis, chemical vapor decomposition and combustion 
synthesis. 
 
1.3.1 Liquid Phase Synthesis Methods 
Sol-gel processing, a wet chemical synthesis approach, generates magnetic 
nanoparticles in a multistep process by gelation, precipitation, and hydrothermal 
treatment [14].The process starts with a chemical solution which acts as the precursor for 
discrete particles. Metal alkoxides and metal chlorides are the common precursors, and 
they undergo various forms of hydrolysis and polycondensation reactions. Metal oxides 
form by connecting the metal centers with oxo (M-O-M) or hydroxo (M-OH-M) bridges. 
This solution forms a gel-like system containing both liquid phase and solid phase 
morphologies including discrete particles. The remaining solvent is removed by a drying 
process, and this result in significant gel shrinkage and densification. During the solvent 
removal process, imposed structural template changes influence the ultimate nanoparticle 
microstructure.  A thermal treatment process is often necessary to obtain further 
polycondensation and enhance mechanical properties and structural stability. Size 
distribution of semiconductor, metal, and metal oxide nanoparticles can be manipulated 
by either dopant introduction [15] or heat treatment [16]. Dong and Zu [17] synthesized 
α-Fe2O3 using sol-gel synthesis from Fe(III) salts. First, an aqueous solution of FeCl3 and 
a mixture of ethylene oxide (EO) and absolute ethanol (EtOH) were cooled in an ice bath. 
Then a mixture of EO and EtOH was slowly dropped into an aqueous solution of FeCl3. 
A red–brown sol formed first for all the samples, and some of the sol became a gel. The 
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sols and gels were heated at 200°C to drive out by-products. After further heating at 
300°C, Fe2O3 nanoparticles were obtained.  
Another wet chemical iron oxide nanoparticle synthesis method is coprecipitation 
of Fe+2, Fe+3 aqueous salt solutions by addition of a base [18-21]. Fe2+ and Fe3+ ratio, 
media pH and ionic strength, and salt type such as chlorides, sulphates, nitrates, 
perchlorates control final nanoparticle size, shape and composition. When a base is added 
to an aqueous mixture of Fe2+ and Fe3+ chloride at 1:2 molar ratio, magnetite is obtained. 
The color of the precipitated magnetite is black. The overall chemical reaction can be 
written as follows:  
                                                                    (1) 
This method is also widely used to synthesize other nanoparticles like CdSnO3 
semiconducting oxide [22], ZnS and CdS particles [23] and Mn-doped ZnO 
nanocrystalline particles [24]. 
In the inverse microemulsion method, two inmiscible liquids (usually, water and 
oil) and a surfactant form the microemulsion system. Droplets of water-in-oil or oil-in-
water are stabilized by surfactants when small amounts of water or oil are used, 
respectively. The droplet size can be precisely controlled in the nanometer range by 
changing the water or oil to surfactant ratio. These nanodroplets, containing precursor 
magnetic nanoparticle ions, can be used as nanoreactors to carry out the chemical 
reactions required for particle nucleation. Particle growth occurs by recruiting precursor 
ions and precipitate molecules from droplets void of particles [25, 26]. Chin and Yaacop 
[27] used a water in oil microemulsion system to prepare magnetic iron oxide 
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nanoparticles. They were able to synthesize 10 nm diameter spherical superparamagnetic 
iron oxide nanoparticles. 
Another wet chemical synthesis method to synthesize magnetic nanoparticles is 
polymer matrix-mediated synthesis [28]. In this method nanoscale magnetic particles use 
a rigid structure as a host or matrix for growth. Organic resins, polymers, zeolite and 
mesoporous solids have been used as host materials. The host provides sites for 
nanoparticle nucleation and controls the final synthesized nanoparticle size [29]. 
Radhakrishnan et al. [30] synthesized the ferric oxide nanoparticle powder by first 
forming a complex of ferric chloride (FeCl3) with polymers of polyethylene oxide, 
polyacrylamide and polyvinyl pyrrolidone then reacting the same with stoichiometric 
proportions of ammonium hydroxide or sodium hydroxide.  
 
1.3.2 Gas Phase Synthesis Methods 
In vapor-phase nanoparticle synthesis, conditions are created where the vapor 
phase mixture is thermodynamically unstable relative to solid nanoparticle formation. 
Laser ablation is a common nanoparticle gas synthesis method. A laser beam is used to 
evaporate material from a target material into a surrounding gas, where it condenses to 
form particles [31, 32]. Ablation experimental conditions, including laser wavelength, 
power, gas type and gas pressure, can be changed to control the final nanoparticle size 
and morphology. In plasma nanoparticle synthesis, microwaves generate plasma by gas 
ionization, which transfers the heat necessary for vaporization and chemical reactions to 
occur [33-35]. Plasma temperatures as high as 1000°C can be achieved using this 
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technique, leading to fast chemical reactions forming nanoparticles. In this method base 
pressure, gas pressure and RF power can be modified to change the final nanoparticle 
properties. In chemical vapor condensation, vapor phase precursors are brought into a 
hot-wall reactor under conditions that favor particle nucleation in the vapor phase rather 
than film deposition on the wall [36, 37]. In this process, the most important process 
parameters determining the quality and usability of the nanopowders are the total 
pressure (typical range from 100 to 100,000 Pa), the precursor material (decomposition 
kinetics and ligands determining the impurity level), the partial pressure of the precursor 
(determining the production rate and particle size), the temperature or power of the 
energy source, the carrier gas (mass flow determining the residence time) and the reactor 
geometry. 
Another vapor phase nanoparticle synthesis method, which is used in this 
dissertation, is combustion (or flame) synthesis. Flame synthesis is widely used for the 
manufacture of bulk nanoparticle quantities. Silica, titania and carbon black nanoparticles 
are predominately manufactured using flame synthesis with typical production rates of 
100 metric tons per day and annual production rates of several million metric tons. These 
powders are used as reinforcing agents, opacifiers, pigments, and in optical fiber 
fabrication [38]. In recent years investigators have re-examined combustion synthesis 
techniques as a means to engineer advanced materials designed at the microscopic level. 
In particular, gas-phase combustion synthesis has been extended to production of 
particles for use in high-temperature superconductors [39], electronic substrates [40], and 
catalytic applications [41, 42]. 
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To understand how combustion synthesis works, it is necessary to understand 
particle formation and growth in the flame. Precursor material is injected in the burner as 
a gas, droplets or solid particles. When liquid or solid precursors are exposed to high 
flame temperatures, they evaporate into vapors that in turn react to form monomers. 
Monomers then cluster, and primary particle homogeneous nucleation occurs. The 
primary particles collide, coalesce, and provide surface growth sites. When the 
characteristic coalescence time is of the same order as the characteristic collision time, 
branchy agglomerates of primary particles are formed. These agglomerates are physically 
held together by weak bonds which can be readily broken. Nucleation, deposition, 
coalescence and agglomeration processes are strong functions of system conditions such 
as temperature, pressure, burner configuration, and reactant concentrations. When 
branchy agglomerates are exposed to high temperatures, or long residence times, they 
completely collapse or coalesce to form uniform individual particles with larger 
characteristic dimensions [43]. 
Gas phase combustion synthesis, or flame synthesis, has significant advantages 
over liquid phase synthesis processes. Gas grown materials generally possess higher 
purity levels compared to liquid or solid state processes. In addition, flames produce self-
purifying high temperatures and the heat of combustion activates precursor pyrolysis, 
hydrolysis, precursor droplet vaporization, and oxidation. Combustion synthesis allows 
control of particle size, size distribution, phase and composition by altering flame 
operating conditions such as temperature, reactant concentration, stoichometry, pressure, 
turbulence, burner configuration, precursor injection location, particle collection location, 
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supplementary laser irradiation, and external electric fields among others. Flame 
synthesis usually occurs as a single step process, whereas wet chemical methods take 
multiple steps. The flame synthesized final product requires no subsequent post-
processing such as washing, and this solvent free processing leads to less process waste. 
Most importantly, combustion synthesis is an easily scalable process that can achieve 
high product yields and large, continuous production rates [44]. Flame technology has 
high potential for inexpensive nanoparticle manufacturing. For instance flame synthesis 
produces the cheapest submicron powder, titania, on the market today ($1/lb, including 
finishing cost) [43]. 
Combustion synthesis has previously been used to produce iron oxide 
nanoparticles. Janzen and Roth [45] synthesized 4-12 nm iron oxide nanoparticles via a 
gas phase route using a low pressure H2/O2/Ar flame. Iron pentacarbonyl (Fe(CO)5) at 
concentrations from 262 to 2096 ppm was the precursor material. Particles were analyzed 
in situ according to their mass and charge by means of a particle mass spectrometer 
(PMS). BET-absorption and transmission electron microscopy (TEM) was used to 
determine particle surface area, size, and structure ex situ. Experimental results were 
verified by a theoretical model including the calculations of H2/O2/Ar gas flows as well 
as transport properties of the burner stabilized flame and particle dynamics. The results 
indicate compact, spherical particles in the size range of 3 to 6 nm, depending on the flow 
coordinate and the dopant concentration.  
Zachariah [46] used a premixed methane/oxygen flame to produce silicon coated 
iron oxide nanoparticles. Iron pentacarbonyl and hexamethyldisiloxane were used as 
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magnetic and non-magnetic precursor materials. X-ray diffraction, electron microscopy, 
Mossbauer spectroscopy and magnetization data measured by SQUID magnetometer 
showed that 30-100 nm diameter composite particles containing 5-10 nm Fe2O3 encased 
in silica were formed. By controlling precursor loading and flame temperature, the silica 
coating of individual iron oxide nanoparticles and cluster aggregation rate were 
controlled. The synthesized composite nanoparticles showed superparamagnetic 
behavior. However a premixed flame represents a limiting case of co-flow diffusion 
flames, resulting in fast precursor conversion at high temperatures followed by high 
collision rates and immediate particle coalescence, which produces larger particles 
compared to coflow diffusion flames [47].   
Xing et al. [48] used a counterflow diffusion flame reactor in which two 
rectangular channels carrying combustion gases were positioned opposite each other. 
They used hydrogen as the fuel and oxygen as the oxidizer. Gases exiting each channel 
imposed upon each other at a gas stagnation plane to synthesize hexagonal and cubic iron 
oxide nanoparticles with primary size of 40 nm.  
Despite these studies, there is a lack of data in the literature showing size and 
chemistry control of synthesized iron oxide nanoparticles by varying the experimental 
flame conditions. Synthesizing bulk amounts of iron oxide nanoparticles with an easy to 
scale up and cheap method is very important if nanoparticles are to be used in various 
industrial applications or for treating human disease. Combustion synthesis offers unique 
advantages, however a detailed investigation should be performed to determine the flame 
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configuration, precursor properties, and gas flow rates which yield optimal iron oxide 
size, chemistry and morphology.  
 
1.4 Applications of Superparamagnetic Nanoparticles in Biomedical Sciences and 
Medicine 
 
Superparamagnetic iron oxide nanoparticles, such as γFe2O3 and Fe3O4, have been 
widely used in biomedical applications and medicine for more than 30 years due to the 
their unique property of exhibiting magnetic behavior only in the presence of a magnetic 
field [4]. Nanoparticles are used to diagnose and treat diseases ranging from cancer to 
atherosclerosis to glaucoma. They are used in magnetic resonance imaging, 
hyperthermia, drug and gene delivery, cell separation and purification and tissue 
engineering [4]. 
 
1.4.1 Coating and Functionalization of Superparamagnetic Nanoparticles 
Nanoparticles are often specifically targeted to a biological tissue or cell type. A 
ligand for a target cell receptor is attached to a coated nanoparticle or carrier-drug 
conjugate. However, the nanoparticle coating material should be chosen carefully. 
Nanoparticle coatings composed of both inorganic and polymeric materials have been 
studied [4]. Polymeric coating materials can be classified as synthetic or natural. 
Polymers based on polyethylene-co-vinyl acetate, polyvinylpyrrolidone (PVP), 
polylactic-co-glycolic acid (PLGA), polyethyleneglycol (PEG), and polyvinyl alcohol 
(PVA), are typical synthetic polymer coatings [49, 50]. Gelatin, dextran, chitosan, and 
pullulan can be used as natural polymer coatings [51-53]. Various surfactants, such as 
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sodium oleate, dodecylamine, and sodium carboxymethylcellulose are also usually used 
to enhance nanoparticle dispersion in an aqueous medium [54, 55].  
Gupta and Curtis [56] coated superparamagnetic nanoparticles with PEG through 
chemical precipitation of ferric and ferrous salts and studied the influence of  PEG coated 
superparamagnetic nanoparticles on human fibroblasts. They found that PEG coated 
nanoparticles did not affect cell adhesion and cell morphology. They used TEM, SEM 
and light and fluorescence microscopy techniques to show that uncoated magnetic 
nanoparticles which were internalized within the fibroblast cytoplasm formed vacuoles 
while surface modified PEG-coated nanoparticles did not change cell behavior. 
Pradhan et al. [57] investigated in vitro toxicity and cellular interactions of lauric 
acid and dextran-coated magnetite nanoparticles with mouse fibroblast and human 
cervical carcinoma cells. Lauric acid-coated magnetite nanoparticles were more toxic 
than dextran-coated magnetite nanoparticles. Cellular uptake of lauric acid-coated 
magnetic nanoparticles was more than that of dextran-coated magnetite nanoparticles.  
Wilhelm et al. [58] synthesized anionic nanoparticles by alkalizing Fe+2 and Fe+3 
salts. These anionic nanoparticles showed a high affinity for the cell membrane and thus 
were captured by cells with an efficiency three orders of magnitude higher than the 
widely used dextran-coated iron oxide nanoparticles. The surface coating of anionic 
particles with albumin strongly reduced non specific interactions with the plasma 
membrane as well as overall cell uptake. It also restored the ability to induce specific 
interactions with targeted cells by coadsorption of a specific ligand on the particle 
surface. 
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Targeted nanoparticles can be synthesized by binding biological molecules such 
as antibodies, proteins, and ligands to the polymer surfaces using amide or ester chemical 
coupling methods [4]. There could be numerous ligands that could be used target cell 
surface receptors. Some possible candidates for conjugating to nanoparticles are as 
follows. Transforming growth factor-α (TGF-α) can be used to promote cell proliferation 
and differentiation and may be important for normal wound healing [59]. Nerve growth 
factor can be used to promote neurite outgrowth and neural cell survival [60]. Pullulan, a 
non toxic, non-immunogenic, non-antigenic material, can be used to increase water 
solubility or to expand the plasma [61]. Elastin can be used as a cross-linking protein in 
the extracellular matrix that provides elasticity for tissues [62]. Albumin as the major 
serum protein can be used for binding a wide variety of lipophilic compounds including 
steroids [63]. Tat peptide can be used for enhancing intracellular delivery and RGD 
peptide can be used for increasing cell spreading and differentiation [64]. Folic acid as a 
poorly immunogenic material can be used to target cancer cells [65]. Hydrophilic coating 
molecules should be attached to nanoparticles using linker molecules such as 1-ethyl-3-
dimethylaminopropyl carbodi-imide hydrochloride (EDCI), N-succinimidyl 3-2-
pyridyldithio propionate (SPDP), N-hydroxysuccinimide or N, N’ methylene bis 
acrylamide (MBA) [66]. Gupta [67, 68] synthesized superparamagnetic iron oxide 
nanoparticles with specific shape and size and coupled them to insulin, lactoferrin and 
ceruloplasmin for targeting to cell surface receptors. This prevented nanoparticle 
endocytosis. This suggests that cell response can be directed via specifically engineered 
particle surfaces. Surface functionalized nanoparticles showed high affinity for cell 
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surface receptor mainly due to ligand–receptor interactions. Their specific attachment to 
cell surface offers the opportunity to label the cells with magnetic particles while 
reducing nonspecific phagocytosis. 
Nanoparticles have been widely used to target specific cells in the body. Zhou et 
al. [69] completed a transmission electron microscopy (TEM) study to investigate the 
ability of magnetic nanoparticles (MNPs) to target breast cancer cells in mice. MNPs 
were functionalized using luteinizing hormone releasing hormone (LHRH), whose 
receptors are expressed in most types of breast cancer cells. LHRH conjugated MNPs 
were injected intravenously into female nude mice bearing tumors for thirty days. 20 
hours after MNP injection these mice were sacrificed. Tumors and periphery organs 
including livers, lungs and kidneys were collected for analysis. Distribution of 
nanoparticles in cells was investigated using TEM. They found that dispersive LHRH 
conjugated MNPs were distributed in tumor cells and cells in lungs and livers. They did 
not observe any LHRH conjugated MNP in kidney cells. Additionally, LHRH conjugated 
magnetic nanoparticles had a tendency to aggregate and form clusters in tumor cells and 
cells in lungs where metastases were developed.  
Magnetic nanoparticles have also been used to target specific intracellular 
organelles. Becker et al. [70] investigated cellular uptake of superparamagnetic Fe3O4 
iron oxide nanoparticles coated with a lipid bilayer and conjugated to streptavidin–
fluorescein isothiocyanate (FITC) for targeting subcellular compartments. They 
synthesized MNPs by coprecipitation of Fe+2 and Fe+3 salts with cis-9-octadecenoic acid 
sodium salt (oleate) which yielded paramagnetic iron oxide cores coated with an oleate 
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lipid bilayer. Biotin-conjugated MNPs were further functionalized by binding the 
fluorescent tag streptavidin– FITC. MNPs were effectively taken up into cells and even 
after the uptake into cells, MNPs showed magnetic activity. Such FITC-MNPs were 
localized in the lysosomal compartment of cells which suggests a receptor-mediated 
uptake mechanism. 
Bertorelle et al. [71] synthesized magnetic fluorescent nanoparticles with 
magnetite core using chemical oxidation methods to label living cells. The bifunctional 
nanoparticles possessed a magnetic oxide core composed of a dimercaptosuccinic acid 
(DMSA) ligand at the surface which was covalently attached to a fluorescent dye. 
Fluorescence microscopy and magnetophoresis showed that the nanoparticles exhibited a 
high cell affinity. Fluorescence microscopy was also used to monitor the magnetic 
nanoparticle localization patterns inside cells. They observed two types of magnetic 
labeling: nanoparticle adsorption to the cell membrane and nanoparticle internalization 
inside the cell. After internalization, nanoparticles were restricted inside endosomes, 
which are endocytotic pathway vesicles inside the cells roughly 300-400nm in diameter. 
They demonstrated that endosome movement could be directed inside the cell by external 
magnetic fields, and small fluorescent chains of magnetic endosomes were formed in the 
cell cytoplasm in the applied magnetic field direction.  
 
1.4.2 Superparamagnetic Nanoparticles in MRI 
Modern MRI techniques to differentiate diseased tissue, tumors, inflammation, 
and microscopic blood vessels use contrast agents to improve signal intensity [72]. 
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Conventional contrast agents used are either paramagnetic metal ions such as Mn2+ and 
Fe3+ or rare earth chelates such as Gd3+ [72]. However these agents result in some side 
effects.  For instance, free manganese is known to cause fetal toxicity in the 
cardiovascular system, central nervous system, lung, and liver [73], while gadolinium 
causes serious kidney damage [74]. Also, those agents have low circulating times 
throughout the body, which makes complete MRI analysis difficult [75]. Conventional 
agents are also only capable of enhancing signal intensity during imaging and they cannot 
carry therapeutic agents [76]. Magnetic nanoparticles have low toxicity levels and longer 
circulating time in the body. They can increase MR imaging efficiency by increasing 
tissue contrast while at the same time working as a targeted drug delivery system. 
Specifically superparamagnetic iron oxide nanoparticles appear dark on MRI images, 
making them a highly sensitive contrast agent for detection of vascular tissues such as 
tumors [77, 78]. 
 
1.4.3 Superparamagnetic Nanoparticles in Hyperthermia 
In addition to current standard cancer therapies such as surgery, chemotherapy, 
hyperthermia is also being used in clinical practice [79]. In whole body hyperthermia, the 
body temperature is set at 41.8 °C [80].  Local heat generation can also be achieved by 
microwave radiation, capacitive or inductive coupling of radiofrequency fields, implanted 
electrodes, ultrasound, or by lasers. Alternatively, magnetic nanoparticles can be loaded 
in the tumor, and tumor can be heated using an external alternating magnetic field. 
Magnetic nanoparticles are currently being investigated for drug targeting to tumors 
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through blood circulation and creating local heating. [81]. For magnetic hyperthermia 
applications, superparamagnetic nanoparticles were injected into a tumor, and when 
exposed to an oscillating magnetic field and they kill the cancer cells without further 
damaging surrounding tissue [82-85].  
 
1.4.4 Superparamagnetic Nanoparticles in Drug and Gene Delivery 
Superparamagnetic nanoparticles are widely used to target drugs and genes to the 
location where they are needed to treat diseases like cancer and atherosclerosis, among 
others. A major disadvantage of most chemotherapeutic approaches to cancer treatment is 
the fact that they are non-specific. Therapeutic drugs are generally toxic. When these 
drugs are systemically distributed by intravenous administration, the drugs attack normal 
healthy cells as well which contributes to therapeutic side effects. Since the 1970’s, 
magnetic nanoparticles have been investigated as targeted treatment agents to reduce the 
systematic side effects of chemotherapy drugs [86, 87]. Total drug administered and drug 
side effects can both be reduced by targeting the drugs to the locations where they are 
needed. In nanoparticle targeted drug delivery, the drug-nanoparticle complex is injected 
intravenously. Drugs can then be targeted to the tumor locations using high gradient, 
external magnetic fields generated by permanent magnets. Once the magnetic carrier 
reaches the tumor, the therapeutic agent is released from the magnetic carrier, either via 
enzymatic activity or through changes in physiological conditions such as pH, osmolality, 
or temperature [88]. Similar principles were applied to therapeutic gene delivery to 
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specific targets in vivo [89]. Specifically, gene vectors associated with superparamagnetic 
nanoparticles were used to deliver genes delivery to target cells [90, 91]. 
 
1.4.5 Superparamagnetic Nanoparticles for Cell Separation and Purification 
Isolation and separation of specific cells and molecules are vital to many areas of 
biosciences and biotechnology, and are the most documented and currently the most 
useful application of magnetic nanoparticles. Various magnetic particles have been 
developed as magnetic carriers in separation processes including purification and 
immunoassays [92-94]. In magnetic cell separation, antibodies attached to the magnetic 
nanoparticles are used to tag cells of interest. The cell sample is processed through a 
column that generates a magnetic field when placed within the separator instrument, 
retaining the labeled cells. In some systems a simple magnet placed next to the cell 
sample directly retains labeled cells within the tube while supernatant is drawn off [95].  
 
1.4.6 Applications of Magnetic Nanoparticles in Tissue Engineering 
Tissue engineering is an interdisciplinary field that applies the principles of 
engineering and life sciences toward the development of biological substitutes that 
restore, maintain, or improve tissue function or a whole organ [96]. Tissue engineering 
scaffolds have been made by traditional processes, including solvent casting, freeze-
drying, phase separation and gas foaming all of which can produce interconnected 
microporous scaffolds with a certain degree of oriented pore structure [97]. However, the 
connectivity created by these techniques is a result of processing variables such as 
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solvent evaporation and porogen particle contact, rather than a predetermined engineering 
design. Precise control over internal architecture is extremely difficult. For this reason a 
new manufacturing technique called solid freeform fabrication was developed to 
manufacture scaffolds layer by layer and allow improved architectural control.  
A broad array of solid freeform fabrication methods have been developed to 
manufacture products that incorporate living cells into their systems [98, 99]. Syringe-
based cell deposition is a form of solid freeform fabrication that performs 
extrusion/jetting-based processes to build 3D tissue scaffolds layer by layer [100, 101]. 
Another method called rapid prototyping combines the strengths of injection molding 
with those of solid freeform fabrication. Three-dimensional pre-seeded implants can be 
fabricated without custom-tooling, enabling efficient production of patient-specific 
implants [102, 103].  Inkjet-based cell printing uses a modified computer printer and an 
ink cartridge, in which cells are suspended separately. The cells were subsequently 
printed as a kind of ink onto several biopapers made from biocompatible materials like 
soy agar and collagen gel [104-106]. Microcontact printing generates mammalian cell 
patterns on porous scaffolds for tissue engineering using replica printing. Cell patterns 
were transferred directly from topographically patterned stamps onto porous scaffolds or 
onto fibronectin-coated glass slides. Stamps inked with cell suspensions allowed repeated 
substrate patterning. This approach enables control of the spatial scaffold invasion, which 
promotes hierarchical cell organization and controls cell–cell interactions as a step in 
preserving cell phenotype [107, 108].  
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Khalil et al. [109], developed a solid freeform direct cell writing system for the 
freeform construction of 3D tissue scaffolds. The system was designed to operate at room 
temperature and low-pressure conditions and to deposit living cells, growth factors, or 
other bioactive compounds in controlled amounts with precise spatial positioning. The 
multi-nozzle deposition system applied solid freeform fabrication techniques along with 
computer aided modeling of heterogeneous structures to build tissue scaffolds. The 
accuracy of the positioning system was 10 μm, though the deposition method and the 
distance between the nozzle tip and the substrate affected this value. The designed 
scaffold model was processed by the data processing system and converted into a layered 
process tool path. The motion control system was driven by the layered manufacturing 
technique and the material delivery system consisted of multiple nozzles with different 
types and sizes. This enabled the deposition of specified biopolymers with different 
viscosities for constructing 3D tissue scaffolds. Four types of the nozzles were used in the 
system: solenoid-actuated nozzles, piezoelectric glass capillary nozzles, pneumatic 
syringe nozzles, and spray nozzles, with size ranges varying from 30 μm to 500 μm. The 
system could continuously extrude biopolymer gels, or form biopolymers in single 
droplets with picoliter volumes. The multiple nozzle capability allowed the users to 
simultaneously deposit cells, growth factors, and scaffold materials, thus enabling the 
construction of heterogeneous scaffolds with bioactive compounds, or establishing 
functional gradient scaffolds with different mechanical/structural properties in different 
scaffold regions. 
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Chang et al. [110] used the solid freeform fabrication-based direct cell writing 
system developed by Khalil et al. [109] and examined the effect of solid freeform 
fabrication–based direct cell writing process, focusing on dispensing pressure and nozzle 
size, on the viability and functional behavior of HepG2 cells encapsulated within alginate. 
Their experimental results revealed a process-induced mechanical damage to cell 
membrane integrity, which caused a quantifiable loss in cell viability when dispensing 
pressure and nozzle size were changed. The experimental results also showed that a 
recovery period may be required following direct cell writing process.  
However none of the previous techniques used active patterning capabilities of 
magnetic forces and magnetic nanoparticles. Ito et al. first used magnetic nanoparticles to 
establish three-dimensional, in vivo-like tissues consisting of various cell types for tissue 
engineering [111]. Magnetic force was used to construct a heterotypic, layered co-culture 
system of rat hepatocytes and human aortic endothelial cells (HAECs). Positively 
charged magnetite cationic liposomes were used to improve nanoparticle uptake inside 
the cells. These nanoparticles accumulated in HAECs at a concentration of 38 pg of 
magnetite per cell. Magnetically labeled HAECs specifically accumulated onto 
hepatocyte monolayers at sites where a magnet (4000 G) was placed and heterotypic, 
layered constructs were manufactured. This new co-cultured construct significantly 
enhanced albumin secretion by hepatocytes, when compared with homotypic cultures of 
hepatocytes or heterotypic co-cultures of hepatocytes and HAECs without magnets.  
Perea et al. [112] presented a novel strategy based on the use of 
superparamagnetic nanoparticles to obtain an endothelial cell lining on the luminal 
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surface of vascular conduits. These nanoparticle loaded endothelial cells were also 
detected non-invasively by MRI. Human umbilical vein endothelial cells (HUVECs) 
were loaded with clinically approved superparamagnetic nanoparticles, and cell viability 
and eNOS expression were not affected by nanoparticle uptake. An electromagnet was 
used to deliver magnetically labeled cells onto a PTFE tubular graft and endothelium was 
detected with a 1,5T MRI scanner. Tubular scaffolds were seeded using magnetic cell 
delivery technique which enables the non-invasive imaging of the cells from the 
substrate. This also enables assessment of the quality of cell delivery procedures. 
However no studies have been performed in the literature to create 3D tissue 
engineered scaffolds containing precisely positioned nanoparticles or cells loaded with 
magnetic nanoparticles.  
 
1.5  Magnetic Nanoparticle Toxicity Mechanisms 
Nanoparticles appear to have some toxic effects that are unusual and not seen 
with larger particles. Two primary mechanisms for nanoparticle toxicity have been 
proposed: reactive oxygen species (ROS) formation and actin cytoskeleton disruption. 
 
1.5.1 Nanoparticle Induced Reactive Oxygen Species Formation 
Nanoparticles increase reactive oxygen species formation when taken inside cells 
[113]. Reactive oxygen species (ROS) are ions or very small molecules including oxygen 
ions, free radicals, and peroxides, both inorganic and organic. They are highly reactive 
due to the presence of unpaired valence shell electrons. ROS form as a natural byproduct 
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of normal oxygen metabolism and have important roles in cell signaling. However, 
during times of environmental stress, ROS levels can increase dramatically, which can 
result in significant damage to cell structures. High ROS levels are known as oxidative 
stress.  
Nanoparticles might result in ROS formation in several different ways. Reactive 
oxygen species can be generated directly from free radicals on the nanoparticle surface. 
Transition metal nanoparticles like iron can generate reactive oxygen species by acting as 
catalysts in Fenton-type reactions that form hydroxyl radicals [114]. Or nanoparticle 
uptake might alter the mitochondrial functions or physically damage the mitochondrial 
membrane to contribute to ROS formation and oxidative stress [115, 116].  
Several different nanoparticle types were already investigated for ROS induced 
toxicity. Combustion derived nanoparticles were found to cause inflammation via 
oxidative stress and activation of redox-sensitive transcription factors [117]. Combustion 
is considered a source of toxic chemicals and particles [118]. Combustion derived 
nanoparticles include diesel soot, welding fume, carbon black and fly-ash particulates. 
Their combustion origin, small size, universal injury mechanism and common 
translocation properties united them, and they have the potential to result in a range of 
adverse effects in the lungs and other organs. These nanoparticles all cause oxidative 
stress as a combined result of their pathogenic mechanism. This oxidative stress can 
cause inflammation and oxidative compounds in epithelium which might lead to 
carcinogenesis. Combustion derived nanoparticles are known to be a potential hazard to 
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the lungs and other systems through the oxidative stress, inflammation and 
carcinogenesis.  
Transition metals have also been shown to induce ROS [119]. They are known to 
cause inflammation via oxidative stress and activation of redox sensitive transcription 
factors [120, 121]. They contribute to the observed health effects like fibrosis, chronic 
inflammatory lung disease, and cancer. When transition metals and polycylic aromatic 
hydrocarbons (PAHs) interact with the lining fluids of the lung, they undergo cycling 
redox reactions that produce ROS [117]. Particles also might result in defects in cell’s 
genetic material so called genotoxicity. Each particle has its own unique physicochemical 
characteristic, so mechanisms involved in particle-induced genotoxicity are not clear. 
Interaction of PAHs with cells may cause genotoxicity and this might cause DNA 
adducts [122]. Alternatively, ROS induced by the transition metals might also result in 
DNA strand breakage [123]. Size and iron release from fly ash has been found to lead 
radical generation and oxidative stress which also result in genotoxicity [124]. 
 
1.5.2 Nanoparticle Induced Actin Cytoskeleton Disruption 
After MNP endocytosis, the nanoparticles may disrupt the cell cytoskeleton. The 
cytoskeleton is a dynamic structure that maintains cell shape, protects the cell, enables 
cellular motion, and plays important roles in both intracellular transport and cellular 
division. Eukaryotic cells contain three main kinds of cytoskeletal filaments, namely 
microfilaments (actin filaments), intermediate filaments, and microtubules [125]. Actin 
filaments are around 5-9 nm in diameter, and they are composed of two tangled actin 
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chains. Actin filaments are mainly concentrated just beneath the cell membrane, and they 
are in charge of resisting tension and maintaining cellular shape, forming cytoplasmic 
protuberances, and participating in cell-to-cell or cell-to-matrix junctions. In relation with 
these roles, actin filaments are essential to mechanotransduction. They are also important 
for cytokinesis and, along with myosin, muscular contraction. Actin/myosin interactions 
also help produce cytoplasmic streaming in most cells [126]. The investigation of actin 
filament changes is very important in understanding toxicity caused by nanoparticle 
endocytosis. 
There is very limited data representing actin cytoskeletal changes in response to 
nanoparticle uptake. Gupta and Curtis investigated the effect of PEG coated nanoparticles 
on the fibroblast cell cytoskeleton compared to the non coated nanoparticles [56]. Their 
findings showed that in control cells, the microfilaments were well organized in thick 
bundles forming stress fibers while in cells loaded with non coated nanoparticles the actin 
fibers were less defined and visibly disorganized in comparison to control cells. They 
also showed that the microtubules form a dense network equally distributed around the 
nucleus in the whole cell volume.  
 
1.5.3 Relation between Reactive Oxygen Species Formation and Actin Cytoskeleton 
Disruption 
Although a large amount of evidence indicates potential links between ROS 
release, actin cytoskeleton disruption, and apoptosis, the actual mechanism which links 
these processes remains unknown. Current studies propose a number of possible 
mechanisms which couple changes in actin dynamics to cell death. The regulation of the 
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voltage dependent anion channel (VDAC) results in the anti-apoptotic activity of gelsolin 
to occur [127, 128]. The VDAC is a mitochondrial membrane pore which is responsible 
for sustaining mitochondrial membrane potential and adjusting the release of pro-
apoptotic factors [129]. It is known that actin regulates VDAC closure in 
Neurosporacrassa [130]. In Neurosporacrassa, the actin-stabilizing drug phalloidin 
extended VDAC pore opening and increased ROS levels. Looking at these data F-actin 
dynamics can be considered to have an important role in cell death by regulating VDAC 
in eukaryotic cells and by regulating the activity of several ion channels. 
Rearranging the cytoskeleton structure in response to stress is a fundamental 
process in many eukaryotic cells. A less dynamic cytoskeleton cannot respond effectively 
to such stimuli. If actin disruption plays a role within cell death pathways, a common 
signaling pathway that contributes to cell viability by remodeling the actin cytoskeleton 
may be needed. The pathway not only regulates, but is also regulated by, actin dynamics. 
Constitutive activation of the Ras–cAMP pathway results in mitochondrial dysfunction, 
which leads to problems in upregulating proteins that protect against oxidative stress, and 
this decreases cell lifespan. The Ras pathway is also involved in actin regulation [131] 
and Ras–cAMP pathway and actin may interact to regulate oxidative stress and cell 
viability [132].  
 
1.6 Organization of the dissertation 
The central hypothesis of this thesis is that iron oxide nanoparticles can be 
synthesized with controllable size and morphology by flame synthesis, the synthesized 
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nanoparticles are equally biocompatible as the commercially available ones, and these 
iron oxide nanoparticles can be used to manipulate and track cells and bioactive factors 
within three-dimensional tissue constructs. The thesis is organized as five chapters.  
• Chapter I, the introduction chapter, coverings background on superparamagnetic 
nanoparticles, their applications in medicine and biomedical areas specifically 
MRI, hyperthermia, drug/gene delivery, cell separation and purification and tissue 
engineering, and previous nanoparticle toxicity studies and underlying toxicity 
mechanisms.  
• Chapter II describes the combustion synthesis set-up developed for the direct iron 
oxide nanoparticles synthesis, and control of nanoparticle morphology, 
composition, and size by varying flame configuration, flame temperature, and 
additive loading.  
• Chapter III presents the comparison of flame synthesized iron oxide nanoparticle 
interaction with endothelial cells to commercially available iron oxide 
nanoparticles in terms of toxicity, cellular uptake, cell proliferation. The 
underlying toxicity mechanisms leading to cell death including reactive oxygen 
species formation and actin cytoskeleton disruption are explored.  
• Chapter IV describes a new hybrid nano-bioprinting technique designed which 
facilitates manipulation and tracking of cells and bioactive factors within three-
dimensional tissue constructs. Cell viability is assessed for various nanoparticle 
and alginate concentrations, and nanoparticle manipulation inside the tissue 
scaffolds is demonstrated. The effect of cell dispensing parameters and scaffold 
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biopolymer characteristics on cell viability, nanoparticle movement, and 
bioprinting patterning capabilities of the new hybrid system are studied.  
• Chapter V concludes the dissertation with the summary of the principle findings 
and suggested future work. 
 
  
32 
 
 
CHAPTER II: NANOPARTICLE SYNTHESIS 
 
 
2.1 Introduction 
Superparamagnetic nanoparticle synthesis methods can be grouped into two broad 
areas: liquid phase synthesis (primarily sol-gel) and gas phase synthesis. Sol-gel 
processing can be used to generate nanoparticles in a multistep process through gelation, 
precipitation, and hydrothermal treatment [14]. Iron oxide nanoparticles have been 
synthesized through wet chemical routes by coprecipitation of Fe+2, Fe+3 aqueous salt 
solutions by addition of a base [18-21], polymer matrix-mediated synthesis [28] and 
inverse microemulsions [25, 26]. Various aerosol processing techniques have been 
reported to improve the production yield of nanoparticles including plasma synthesis [33-
35], laser ablation [31, 32], chemical vapor condensation [36, 37]  and  spray pyrolysis 
[133]. 
Recently, it has been shown that combustion synthesis has significant advantages 
over liquid phase synthesis processes. Combustion synthesis is the simplest and most 
economic method for nanoparticle production and is currently used to produce bulk 
carbon black, titania, and silica powders [134]. The flame synthesized materials generally 
possess higher purity levels compared to liquid or solid state processes. In addition, 
flames produce a self-purifying process due to their high temperatures. The heat of 
combustion activates precursor pyrolysis, hydrolysis, precursor droplet vaporization, and 
oxidation. Combustion synthesis allows control of particle size, size distribution, phase 
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and composition by altering flame operating conditions such as temperature, reactant 
concentration, stoichometry, pressure, turbulence, burner configuration, precursor 
injection location, particle collection location, supplementary laser irradiation, and 
external electric fields among others. Flame synthesis usually occurs as a single step 
process, whereas wet chemical methods take multiple steps. The flame synthesized final 
product requires no subsequent post-processing such as washing, and this solvent free 
processing leads to less process waste. Most importantly combustion synthesis has 
proven to be an easily scalable process that can achieve high product yields and large, 
continuous production rates [43, 44, 135]. 
Iron oxide nanoparticles have previously been synthesized using combustion 
synthesis. Janzen and Roth [45] synthesized 4-12 nm iron oxide nanoparticles via a gas 
phase route using a low pressure H2/O2/Ar flame. Zachariah et al. [46] used a premixed 
methane/oxygen flame to produce silicon coated iron oxide nanoparticles. However a 
premixed flame represents a limiting case of co-flow diffusion flames, resulting in fast 
precursor conversion at high temperatures followed by high collision rates, immediate 
particle coalescence, and large particles [47]. Xing et al. [48] used a counterflow 
diffusion flame reactor in which two rectangular channels carrying combustion gases 
were positioned opposite each other. Gases exiting each channel imposed upon each 
other at a gas stagnation plane to synthesize hexagonal and cubic iron oxide nanoparticles 
with primary size of 40 nm.  
Recently, combustion synthesis has been used to produce nano-sized metal oxides 
of different morphologies by inserting solid substrates into the flame. Lee et al. [136] 
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used an inverse diffusion flame to synthesize Ni-catalyzed multiwalled carbon nanotubes 
and nanofibers on a catalytic substrate. The nanomaterial and shape formed were highly 
dependent on flame temperature. Carbon nanofibers were synthesized at temperatures 
lower than 900 K, carbon nanotubes were synthesized between 900 and 1400 K, and iron 
nanorods were synthesized above 1400 K. Flame temperature also affected size for a 
given nanomaterial and shape, since larger diameter carbon nanotubes were observed 
closer to the flame. Later studies showed similar elongated nanomaterial synthesis of 
varied composition using solid substrates. Single crystalline zinc oxide nanowires were 
produced on zinc-plated-steel substrates using an axi-symmetric inverse jet diffusion 
flame, again with larger diameter nanowires produced at higher temperature [137]. 
Similarly, 10 to 100 nm diameter iron oxide nanorods a few microns in length were 
synthesized in a single step by inserting iron probes into an opposed-flow methane oxy-
flame [138].  These new developments in combustion synthesis continue to highlight the 
importance of combustion parameters on nanomaterial properties. 
Flame configuration affects nanoparticle size and morphology. Effect of reactant 
mixing, precursor chemistry, additives and external electric fields on flame synthesized 
silica and titania nanoparticles has previously been characterized [135]. Specifically, 
titania particles synthesized in an inverted diffusion flame were up to 10 times smaller 
than particles produced in a regular diffusion flame, likely due to altered flame 
temperature [139]. However, the effect of flame configuration has not been examined for 
other nanoparticle compositions, specifically iron oxide. 
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In this study, we initially hypothesized that we can synthesize iron oxide 
nanoparticles in an easy to scale up and inexpensive method and further control the final 
nanoparticle morphology and chemistry by changing flame conditions. Iron oxide 
nanoparticles were synthesized using a coflow diffusion flame configuration. Control 
over the final iron oxide morphology and chemistry was provided by controlling three 
parameters: flame configuration, flame temperature and additive loading. The material 
characteristics of the flame synthesized iron oxide nanoparticles, including morphology, 
elemental composition, and particle size were analyzed by transmission electron 
microscopy (TEM), energy dispersive spectroscopy (EDS), and Raman Spectroscopy.  
 
2.2 Experimental Setup 
In the current work, a laboratory scale combustion synthesis and sampling system 
was developed for direct iron oxide nanoparticle synthesis. The combustion synthesis 
system was composed of three main components: the burner, which was used to create a 
high temperature synthesis environment; a liquid precursor delivery system; and two 
particle sampling mechanisms to obtain discrete and bulk material samples via 
thermophoretic deposition. A schematic of the combustion synthesis system is shown in 
Figure 1.  
A co-flow diffusion flame burner consisting of three concentric stainless steel 
tubes with 1/8”, 1/2” and 7/8” diameters was used. An inert argon stream carrying the 
precursor vapor was introduced through the center tube. Oxidizer (oxygen) and methane 
were passed through the second and third tubes respectively to achieve an inverse 
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diffusion flame, or in the reverse order for a diffusion flame configuration. Nitrogen was 
introduced through the methane line to cool the flame temperature. The burner and 
exhaust were surrounded by a rectangular acrylic chimney to facilitate stable burning and 
to prevent ambient air entrainment. 
The gas phase delivery system for the liquid precursors consisted of a temperature 
controlled aluminum canister containing the liquid precursor. Argon gas entered the 
canister and bubbled through the liquid precursor in a convoluted path before exiting to 
the burner. The gas lines, delivery tube, and burner were heated using heat tape 
controlled to a required temperature to prevent precursor condensation. Temperature 
measurements along the delivery system were made with K-type thermocouples and 
OMEGA CNi3222 temperature controller. Rotameters measured oxygen, methane, argon 
and nitrogen flow rates. Studies were completed to examine the time required to reach 
steady state temperatures in the delivery system for different precursor materials. 
Two different sampling systems were developed to analyze the synthesized 
nanoparticles. Bulk nanoparticle samples were collected 10 cm above the flame on a 
water-cooled cold plate by thermophoretic deposition for sampling times of 
approximately 10 minutes. Discrete samples were thermophoretically collected onto 
TEM grids (Electron Microscopy Sciences, carbon film, 300 mesh copper), connected to 
a timer controlled pneumatic cylinder, which was inserted into the flame at different 
heights for sampling times of less than one second (~100 ms). This technique was 
modified and extensively employed by  Dobbins  and Megaridis for  collecting soot from 
flames to study its morphology [140]. 
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Figure 1. Experimental setup schematic 
 
 
 
 
The discrete samples were studied using TEM (JEM-2000FX) to identify particle 
morphology (including particle size) and high-resolution TEM (JEM-2010F FasTEM 
field-emission gun transmission electron microscope) for detailed lattice structure 
examination.  Samples were also examined using TEM-EDS for elemental analysis. The 
iron oxide nanoparticle elemental composition was analyzed using a Renishaw RM1000 
VIS Raman Microspectrometer with 633 nm excitation wavelength. Laser power was 
kept under 25 percent total power to avoid sample degradation and before and after each 
spectrum had been recorded. A visual inspection under white light was completed to 
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detect any compositional changes caused by the laser power. 
Four different synthesis conditions were examined in the study: Case I- inverse 
diffusion flame; Case II- inverse diffusion flame cooled with N2; Case III- diffusion 
flame cooled with N2; and Case IV- inverse diffusion flame with titanium-tetra-
isopropoxide (TTIP), Ti[OCH(CH3)2]4, additive loading.  Table 1 summarizes the 
operating conditions.  All compressed gases (H2, O2, Ar, N2) were obtained from Airgas 
with greater than 99.99% purities. Iron pentacarbonyl, Fe(CO)5, and titanium-tetra-
isopropoxide (TTIP), Ti[OCH(CH3)2]4, were used as the liquid precursors (Alfa-Aesar) 
for the synthesis of iron oxide and titanium oxide, respectively and delivered to the 
reactor as saturated vapors carried by Argon gas. All synthesis conditions were conducted 
under oxygen rich conditions with an equivalence ratio of 0.28 to minimize unwanted 
carbon contamination in synthesized nanoparticles.   
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Table 1. Synthesis conditions 
 
 
 
Case Synthesis 
Condition 
Material 
System 
CH4 
[l/min] 
O2 
[l/min] 
Ar 
[l/min] 
N2 
[l/min] 
Ø 
1 Inv. Diffusion Iron Oxide 0.494 3.546 0.305 - 0.28 
2 Inv. Diffusion Iron Oxide 0.494 3.546 0.305 4.000 0.28 
3 Diffusion Iron Oxide 0.494 3.546 0.305 4.000 0.28 
4 Inv. Diffusion Iron Oxide-
Titania 
0.494 3.546 0.305 - 0.28 
 
 
 
 
2.3 Results 
2.3.1  Case I vs Case II 
The effect of flame temperature on iron oxide nanoparticle chemical composition 
and morphology was examined by comparing an uncooled inverse diffusion flame to an 
N2 cooled inverse diffusion flame. CH4, O2, and Ar gas flow rates were kept constant to 
isolate the effect of N2 gas cooling, and a 0.28 equivalence ratio was used to minimize 
unwanted carbon contamination 
For the Case I conditions given in the Table 1, a 2493K adiabatic flame 
temperature was achieved as calculated by STANJAN program and JANNAF 
thermochemical tables. Raman spectroscopy indicated that nanoparticles were a 
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heterogeneous mixture of two common iron oxide forms: hematite and magnetite (Figure 
2). For hematite, the expected seven photon lines in the Raman spectrum of two A1g 
modes and five Eg modes (225, 498, 247, 293, 299, 412 and 613 cm-1) were observed 
[141]. Since hematite is an antiferromagnetic material, the collective spin movement can 
be excited in a magnon which is also detected by Raman spectroscopy. The intense peak 
observed at 1320 cm-1 is assigned to two-magnon scattering which arises from interaction 
of two magnons created on antiparallel close spin sites [141]. For magnetite, 
disagreements exist in the literature for the Raman peak locations, especially for peaks 
close to reported hematite peaks.  Magnetite has five Raman bands: three T2g, one Eg 
and one A1g (298, 320, 420, 530 and 680 cm-1). For our nanoparticles, we observed wide 
peaks at 320, 530 and 680 cm-1, which are reported in the literature as the characteristic 
magnetite peaks [141]. 
In Case II, the system was cooled to 1686K adiabatic flame temperature by 
flowing 4000 ml/min N2 through the third annulus along with CH4. All other conditions 
were kept constant to obtain the same equivalence ratio of 0.28. Raman spectroscopy of 
synthesized nanoparticles indicated that the nanoparticles were again a heterogenous 
mixture of hematite and magnetite (Figure 2). However, in these cooled conditions, 
almost all hematite peaks were diminished, showing that the final product was primarily 
composed of magnetite. 
TEM analysis was employed to compare iron oxide nanoparticle morphology for 
the two different synthesis conditions as discussed above. Nanoparticles synthesized 
under higher temperature conditions, Case I, were mainly monodispersed 6-12 nm iron 
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oxide nanoparticles and aggregated clusters of these 6-12 nm nanoparticles accompanied 
with larger 50-60 nm polygonal shaped iron oxide nanoparticles (Figure 3A, B).  In 
contrast, nanoparticles synthesized under the cooler conditions in Case II were mainly 6-
12 nm monodispersed iron oxide nanoparticles when they were collected 5mm above the 
burner exit (Figure 3C) and aggregated clusters of these nanoparticles when they were 
collected 50 mm above the burner exit (Figure 3D). 
 
Figure 2. Raman spectroscopy showed nanoparticles synthesized in Case I were a 
heterogeneous mixture of hematite and magnetite. In Case II, N2 addition to the CH4 line 
decreased the flame temperature and hematite peaks, demonstrating that cooler flame 
temperatures produced mainly magnetite nanoparticles.  
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Figure 3. Iron oxide nanoparticles synthesized in Case I conditions were aggregated 
clusters of 6-12 nm nanoparticles and 50-60 nm polygonal nanoparticles (A, B).  
However iron oxide nanoparticles synthesized in Case III conditions were 6-12 nm 
monodisperse nanoparticles (C) and aggregated nanoparticle clusters (D). 
 
 
 
 
2.3.2 Case II vs Case III 
In this study, the effect of flame configuration on iron oxide nanoparticle 
chemical composition and morphology was investigated. CH4, O2, Ar and N2 gas flow 
rates were kept constant, and the locations for fuel and oxidizer injection were 
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reconfigured. In Case II, O2 flowed through the second annulus and CH4 flowed through 
the third annulus to achieve an inverse diffusion flame configuration. In Case III, CH4 
flowed through the second annulus and O2 through the third to obtain a diffusion flame 
configuration. 
No significant differences in nanoparticle chemical composition were observed by 
Raman spectroscopy for the different flame configurations in Case II and Case III (Figure 
4). The effect of flame configuration on the nanoparticle morphology was investigated by 
TEM. Nanoparticles were thermophoretically collected on TEM grids at several flame 
heights above the burner exit to examine the progress of nanoparticle growth along the 
flame axis. For both Case II and Case III conditions, thermophoretic sampling and TEM 
analysis show that only singlet particles exist 5 mm above the burner exit (Figure 5). Iron 
oxide nanoparticles produced by Case II inverse diffusion flame conditions (Figure 6A) 
were smaller compared to nanoparticles produced by Case III diffusion flame conditions 
(Figure 6B). As nanoparticles advanced in the flame, they became more aggregated and 
an increase in nanoparticle size was observed (samples collected 50 mm above the burner 
exit) (Figure 6C, D). 
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Figure 4.  Raman spectroscopy showed that there is no significant difference in terms of 
chemical composition between the particles synthesized using the Case II and Case III 
conditions.  
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Figure 5. A TEM image of nanoparticles collected at the burner exit showed highly 
monodisperse iron oxide nanoparticles 6-12 nm in diameter. 
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Figure 6. Iron oxide nanoparticles produced with Case II (inverse diffusion flame) 
conditions (A) were smaller in size to nanoparticles produced with Case III (diffusion 
flame) conditions (C). As nanoparticles advanced in the flame, they become more 
aggregated and increased in size (B, D). 
 
 
 
2.3.3 Case I vs Case IV 
In Case IV, the effect of TTIP additive loading on nanoparticle chemical 
composition and morphology was examined in the inverse diffusion flame configuration. 
The bubblers containing the precursors were set at the boiling temperatures of TTIP (BP 
= 104°C) and Fe(CO)5 (BP = 103°C) to obtain saturated precursor vapors. The Ar stream 
carrying the Fe(CO)5 flowed through the burner center annulus, and the Ar stream 
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carrying the TTIP flowed through the outer annulus with the CH4. When the Fe(CO)5 
precursor flow was prevented, the sample Raman spectrum showed the standard Raman 
peaks for two well known forms of anatase TiO2 (144, 197, 400, 525, and 650 cm−1), 
indicating that the nanoparticles were mainly composed of the anatase phase of TiO2 
(Figure 7) [142]. The external morphology of the synthesized anatase nanoparticles is 
presented in Figure 8A. In the HRTEM image of the synthesized TiO2 nanoparticles, 
anatase phase nanocrystallites can be identified from the 0.352 nm lattice fringes, which 
corresponds to the (1 0 1) lattice plane of the anatase phase TiO2 (Figure 8B). The lattice 
plane and crystallinity is further evident in the insert of Figure 8B, which corresponds to 
the fast Fourier transformation (FFT) power spectrum of the selected area in the HR-
TEM image (Figure 8B). 
 
 
 
 
Figure 7.  Raman spectrum showed that the nanoparticles were composed of the anatase 
form of TiO2. 
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Figure 8. TEM images of the synthesized anatase nanoparticles (A) and HRTEM images 
of the synthesized nanoparticles including the FFT (insert) (B). 
 
 
 
 
To investigate the effect of TTIP loading on iron oxide nanoparticle morphology 
and chemistry, Ar flowrate carrying the TTIP was set to 100ml/min and Ar flowrate 
carrying the Fe(CO)5 was set to 305ml/min. At this configuration, the synthesized 
nanoparticles were mainly iron oxide (hematite and magnetite forms). TEM images 
showed that these iron oxide nanoparticles were highly monodispersed and spherical in 
shape, with sizes ranging from 50 to 90 nm (Figure 9A). EDS analysis verified the iron 
content of the particles (Figure 9B). The iron oxide nanoparticles synthesized in Case I 
and Case IV conditions were compared to determine the effect of TTIP additive on 
nanoparticle morphology (Figure 10). TTIP loading resulted in synthesis of 
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monodispersed, large iron oxide nanoparticles. The small aggregated iron oxide particles 
observed in Case I conditions (Figure 10A, B) were not observed in Case IV conditions. 
 
 
 
 
 
Figure 9. TEM images of the iron oxide nanoparticles synthesized in Case IV conditions 
showed highly monodisperse 50-90nm size nanoparticles (A). EDS analysis verified the 
nanoparticle iron oxide content (B). 
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Figure 10. TEM analysis verified that nanoparticles synthesized using Case IV (C, D) 
conditions were morphologically different than nanoparticles synthesized using Case I 
conditions (A, B). The nanoparticles synthesized with TiO2 doping were more 
monodisperse with sizes from 50nm-90nm and aggregated small nanoparticles were not 
observed (C, D). 
 
 
 
 
When the Ar flowrate carrying both the TTIP and Fe(CO)5 precursors was set at 
305ml/min, the synthesized nanoparticles were a heterogeneous mixture of anatase and 
iron oxide (hematite and magnetite forms) particles. EDS analysis verified the Ti and Fe 
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content of the heterogeneous mixture (Figure 11A). The Raman spectrum also showed 
the anatase, hematite and magnetite content of the particles (Figure 11B). Carbon peaks 
in Raman spectrum and EDS analysis showed that 305 ml/min TTIP addition resulted in 
some unburned fuel and soot formation.  
 
 
 
 
 
Figure 11. Raman spectrum showed that the synthesized nanoparticles were a 
heterogeneous mixture of anatase, hematite and magnetite nanoparticles when TTIP and 
Fe(CO)5 flowrates were set at 305ml/min (B). EDS analysis also verified Fe, Ti and O 
content of the synthesized nanoparticles (A).  
 
 
 
 
2.4 Discussion 
We now show that hematite αFe2O3 and magnetite Fe3O4 iron oxide nanoparticles, 
which are used in diverse applications from biomedical imaging contrast agents to 
catalysts to gas sensors, can be synthesized using a coflow diffusion flame. The size and 
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morphology of synthesized iron oxide nanoparticles was highly dependent on flame 
temperature, residence time, flame configuration, and additives when CH4, O2, Ar and N2 
gas flow rates were kept constant. A cooled inverse diffusion flame produced 
monodispersed 6-12 nm iron oxide nanoparticles when samples were collected directly 
above the burner. Thus flame synthesis could produce large quantities of small iron oxide 
nanoparticles without any required post-processing.   
The nanoparticle growth mechanism and overall particle morphology primarily 
depend on precursor concentration, flame temperature, and particle flame residence time. 
Additional system parameters, including flame configuration, stoichiometry, gas flow 
rate, and diluent concentration, are important to the extent that they affect flame 
temperature and particle residence time [44]. Since precursor concentration and 
stoichiometry were kept constant in all of our experiments, the morphology of our 
synthesized iron oxide nanoparticles was a function of flame temperature and residence 
time. These parameters varied with flame configuration, coolant flow rate, additive 
loading, and sampling location. Based on our experimental results and careful review of 
the literature, we propose the following growth mechanism for flame synthesized iron 
oxide nanoparticles. 
The iron pentacarbonyl precursor was exposed to high flame temperatures as it 
was injected into the burner. At high temperature, iron oxide monomers formed by gas 
phase chemical reactions. Monomers then polymerized, leading to homogeneous 
nucleation of 6-12 nm diameter primary particles. Depending on flame temperature and 
particle flame residence time, these primary particles remained monodispersed, collided 
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to form branched agglomerates, or coalesced to form larger individual particles [43, 44]. 
When iron oxide nanoparticles were synthesized in a nitrogen cooled inverse diffusion 
flame (Case II, 1686K adiabatic flame temperature) and collected 5 mm above the burner 
exit, the low flame temperature and short residence time resulted in 6-12 nm diameter 
monodispersed nanoparticles (Figure 3C). Under the same synthesis conditions but at a 
higher collection point (50 mm above the burner exit), the longer residence time allowed 
these primary particles to collide and form fractal-like agglomerates consisting of 6-12 
nm primary particles (Figure 3D). Agglomerates formed rather than larger nanoparticles 
because the collision rate was faster than the coalescence rate. However, when iron oxide 
nanoparticles were synthesized in an inverse diffusion flame without cooling (Case I, 
2493K adiabatic flame temperature), the higher flame temperature led to a coalescence 
rate that was faster than the collision rate [46]. In these conditions, even for short flame 
residence times, some of the aggregated primary iron oxide nanoparticle clusters 
coalesced to form larger 50-60 nm spherical and polygonal nanoparticles (Figure 3A, B). 
Despite the varied larger nanoparticle shapes, they likely formed by coalescence of 
smaller primary nanoparticles. These larger nanoparticles do not show any agglomeration 
because any clustered nanoparticles would have coalesced at the high temperature 
locations where the larger nanoparticles formed. 
Diffusion flames generate higher temperatures than inverse diffusion flame 
configurations, and therefore have been shown to produce larger oxide nanoparticles 
(SiO2, SnO2, TiO2, Al2O3) [139]. By altering the position of fuel and oxidant streams in 
methane-air diffusion flame reactors, the average primary particle size of TiO2 powders 
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made by TiCl4 oxidation could be changed by as much as a factor of 10. We now show 
similar results for iron oxide nanoparticles. Even in a nitrogen cooled diffusion flame 
(Case III), nanoparticles experienced higher flame temperatures compared to the inverse 
diffusion flame configuration. Case III also produced a narrow flame front, which could 
have increased the flame temperature. Since the fuel flow rate through the second ring 
was substantially lower than the oxidizer gas flow rate, the flame was positioned near the 
center of the second ring. Iron oxide nanoparticles synthesized in the higher temperature 
diffusion flame configuration coalesced to form larger nanoparticles independent of 
residence time, since the coalescence rate was higher than the collision rate (Figure 6C, 
D). The dilution of the Ar stream carrying the Fe(CO)5 precursor with the adjacent CH4 
stream was not significant since both streams had comparable flow rates of 305 and 494 
ml/min, respectively.  
The presence of additives or dopants affects particle coalescence rate and 
subsequent nanoparticle size and morphology. Wu et a1. [143] found that addition of K+ 
or Na+ during oxide flame synthesis reduced the primary particle size. The particles were 
coated with a charged layer, which reduced particle collision frequency and resulted in a 
narrower particle size distribution and smaller primary particles. Fotou et al. [144] found 
that ferrocene reduced large aggregate formation during silica particle synthesis by SiCl4 
oxidation in a diffusion flame reactor. In our experiments, TTIP was added to the inverse 
diffusion flame configuration in Case IV to determine the effect of additives on iron 
oxide nanoparticle morphology. The additive resulted in synthesis of a mixture of titania 
and 50-90 nm iron oxide nanoparticles. The larger particles were likely synthesized 
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because the TTIP increased flame temperature or created high temperature gradients, 
either of which could increase the coalescence rate. Large temperature gradients in a 
flame can enact strong thermophoretic forces on the newly formed particles. This can 
alter their residence time at the decisive region where oxidation, nucleation, growth, and 
coalescence occur, thus affecting particle size and morphology.  
Flame configuration and additives can affect nanoparticle properties, in addition 
to changing their size and morphology. Zachariah and Huzarewicz [39] synthesized 
submicron YBa2Cu307 particles by pyrolysis of the corresponding aqueous nitrate salts in 
an oxy-hydrogen diffusion flame reactor. They found that making these particles in an 
over-ventilated coflow diffusion flame resulted in super conducting powders while this 
was not the case when the particles were made in a premixed flame configuration at the 
same conditions. Vemury and Pratsinis [145] found that addition of SnCl4 or AlCl3 
enhanced the transformation of anatase to rutile and reduced the specific surface area of 
the product TiO2 made by TiCl4 oxidation in a coflow diffusion flame reactor. In contrast, 
SiCl4 inhibited the transformation of anatase to rutile and increased the specific surface 
area of the product powder in agreement with investigations in hot-wall aerosol flow 
reactors for the effect of silicon [146] and aluminum [147] dopants on titania powders.  
In our experiments, only the cooler flame (Case II) changed iron oxide 
nanoparticle properties by synthesizing less hematite as compared to magnetite. 
Magnetite converts to hematite at elevated temperatures. Experimental research [148-
150] has shown that synthetic magnetite oxidizes first to γ-Fe2O3 (maghemite) and then 
to α-Fe2O3 (hematite) whereas natural magnetite oxidizes only to γ-Fe2O3,usually at more 
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elevated temperatures. Schmidt and Vermaas [151] examined the effect of heating on 
magnetite behavior. They concluded that magnetite goes through two oxidation stages 
when it is heated in air. The first stage is a surface oxidation to hematite, and the second 
stage is a complete oxidation also to hematite. Przepiera and Przepiera [152] also showed 
that precipitated magnetite undergoes the following cycle of thermal transformations in 
atmospheric air: 3232
,
43
2 OFeOFeOFe TTO αγ →→ . These results match with the 
Raman spectrum analysis of samples produced with Case I and Case II configurations. 
The Case II configuration with lower flame temperature resulted in magnetite iron oxide 
nanoparticles. However, some of these nanoparticles transformed into hematite iron oxide 
nanoparticles at elevated temperatures in Case I conditions.  
In all of the experimental configurations investigated in this study O2 was used as 
the oxidizer rather than air since its oxidizer composition is known to have a significant 
effect on final nanoparticle morphology. Pratsinis et al. [139] showed that using pure 
oxygen in a diffusion flame reactor resulted in spherical anatase titania particles. When 
air was used as the oxidant, the particles were rather aggregates with a significant fraction 
of rutile. Using oxygen leads to faster fuel consumption, higher temperatures and short 
flames that accelerate precursor oxidation. 
Flame synthesis is an excellent method for the synthesis of single component, 
high-purity powders of small particle size, high specific surface area and controlled 
particle size distribution. The major disadvantage of flame synthesis is production of 
particle aggregates in certain configurations. Our research suggests that flame 
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configuration, cooling, additive loading, and collection location can control nanoparticle 
size, morphology, and aggregate formation. 
In this study iron oxide nanoparticles were synthesized using a coflow diffusion 
and inverse diffusion flame configuration. The synthesized nanoparticles were composed 
of two well known forms of iron oxide: hematite αFe2O3 and magnetite Fe3O4. 
Nanoparticles synthesized in an inverse diffusion flame configuration were smaller than 
nanoparticles produced in a diffusion flame configuration. Iron oxide nanoparticles 
synthesized in an inverse diffusion flame configuration with N2 cooling showed no large 
iron oxide nanoparticles, indicating that the nanoparticles did not coalescence in the 
lower temperature flame.  Raman spectroscopy showed that the nanoparticles were 
mainly magnetite without hematite, which had dominated in the uncooled inverse 
diffusion flame configuration. When particles were synthesized in the presence of TTIP 
additive, larger monodispersed particles were observed. The results of this study indicate 
that flame synthesis has the potential to create iron oxide nanoparticles with controlled 
morphology and chemistry for various applications, including gas sensor technology and 
biomedical engineering.  
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CHAPTER III: CELLULAR UPTAKE AND TOXICITY STUDIES OF 
SYNTHESIZED IRON OXIDE NANOPARTICLES 
 
 
3.1 Introduction 
We synthesized iron oxide nanoparticles using flame synthesis as described in 
Chapter 2. Our end goal was to use flame synthesized iron oxide nanoparticles in 
biomedical applications. To do so we needed to verify that combustion synthesized iron 
oxide nanoparticles were equally non-toxic as commercially available iron oxide 
nanoparticles. To use the synthesized nanoparticles without negatively affecting human 
health, we also needed to investigate the major mechanisms that lead to nanoparticle 
toxicity. This will enable fabrication of nanoparticles with different composition or shape 
that would suppress these mechanisms. 
Superparamagnetic nanoparticle interactions with endothelial cells are critically 
important, since nanoparticles injected into the bloodstream will directly contact 
endothelial cells lining the inner blood vessel surface. Nanoparticles will need to pass 
through the endothelial cells to reach any targeted tissue or cell in the body. The 
endothelium is also an important target for drug and gene therapy since is important in 
vascular homeostasis. Endothelial cells may be targeted to enhance angiogenesis in 
wound healing, to inhibit angiogenesis in tumor growth, or to decrease permeability and 
inflammation in atherosclerosis [153-155]. Nanoparticles provide a unique opportunity to 
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focus gene and drug therapy on endothelial cells, in particular by binding to endothelial 
cell specific markers [156-159].  
Little is known about the underlying mechanisms resulting in nanoparticle 
toxicity after the cellular nanoparticle uptake. Several mechanisms for nanoparticle-
induced injury of cells and tissues have been proposed and are supported by limited 
experimental evidence. The currently best developed hypothesis for nanoparticle toxicity 
is ROS generation [113]. This is thought to result in protein, DNA and tissue injury. 
There are several hypotheses explaining how nanoparticles generate the ROS.  ROS may 
be directly generated from free radicals on the particle surface. Transition metal 
nanoparticles like iron can generate ROS through acting as catalysts in Fenton-type 
reactions, resulting in hydroxyl radical formation [114]. Or ROS might originate from 
altered mitochondrial function due to nanoparticles uptake into mitochondria [115], 
where they produce physical damage and contribute to oxidative stress [116]. 
Several different materials were investigated in terms of ROS induced toxicity. 
 Human bronchoalveolar carcinoma-derived cells exposed to 70 nm ZnO particles 
showed increased ROS formation and reduced cell viability in a dose and time dependent 
manner [160]. TiO2 nanoparticle uptake into human bronchial epithelial cells prompted a 
concentration-dependent generation of intracellular ROS after 6 hours exposure, and 
ROS formation was statistically different than control cells at concentrations of 10 
μg/cm2 and 50 μg/cm2 [161]. Combustion derived nanoparticles were found to cause 
inflammation via oxidative stress and activation of redox-sensitive transcription factors 
[117]. Transition metals also induce ROS, which results in DNA strand breakage [119]. 
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Oil fly ash generated ROS and oxidative stress in the lungs  [124]. Apopa et al showed 
that uptake of iron oxide nanoparticles with an average diameter of 298nm in human 
microvascular endothelial cells increased ROS which enhanced cell permeability. 
However none of the studies mentioned investigated iron oxide dose dependent ROS 
formation or ROS formation over time.  
After nanoparticle endocytosis, nanoparticles may affect the cell cytoskeleton by 
forming vacuoles in the cell body which disrupt the cell cytoskeleton. Gupta and Curtis 
[68] previously showed that cells incubated with plain iron oxide nanoparticles showed 
cell cytoskeletal disruption. However their results were preliminary, were not 
investigated in detail, and did not show a relationship among iron oxide nanoparticle 
concentration, cytoskeleton disruption, and cell toxicity. Furthermore, the effect of 
nanoparticle-induced ROS generation on actin cytoskeleton disruption has not been 
investigated.  
Actin cytoskeleton disruption and ROS formation were previously hypothesized 
to work in a coupled manner. Studies in yeast showed that decreased actin turnover and 
accumulation of large F-actin aggregates trigger an increase cytosolic ROS [162]. As 
previously mentioned, mitochondria are one of the main sources of ROS formation in 
cells. The reduction in actin dynamics leads to open voltage-dependent anion channels 
that reduce mitochondrial membrane potential (Δψm) which results in increased ROS 
release and sensitivity to apoptosis [132]. Reduced mitochondrial activity results in 
reduced ATP generation, which in turn causes reduced actin dynamics. Mitochondrial 
dysfunction-related ROS release and actin cytoskeleton disruption act as an 
61 
 
 
interconnected system, stimulating each other back and forth. Therefore, ROS and actin 
nanoparticle toxicity should be investigated together.  
In this study, we initially hypothesized that combustion synthesized iron oxide 
nanoparticles were equally compatible to commercially available ones. We further 
hypothesized that iron oxide nanoparticles induce ROS generation in a dose dependent 
manner, and this ROS formation leads to actin cytoskeleton disruption. We first 
investigated the interaction of iron oxide nanoparticle with porcine aortic endothelial 
cells (PAEC). Combustion synthesized nanoparticles were incubated in vitro with PAEC, 
and cell adhesion, viability, and function were compared to cells incubated with 
commercially available iron oxide nanoparticles. Then we investigated the dose 
dependent effect of iron oxide nanoparticle uptake on ROS formation and actin 
cytoskeleton disruption by confocal microscopy. Transmission electron microscopy 
(TEM) was used to image nanoparticles inside the PAEC. A live dead assay was used to 
assess viability of cells loaded with different iron oxide nanoparticle concentrations and 
cells in which ROS formation was blocked. We now show that flame synthesis can 
efficiently produce superparamagnetic iron oxide nanoparticles that are non-toxic to 
endothelial cells, and that increased nanoparticle concentration induces ROS formation 
which disrupts the actin cytoskeleton. 
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3.2 Materials and Methods 
3.2.1 Cell Culture 
Porcine aortic endothelial cells (PAEC), isolated by the collagenase dispersion 
method, were maintained in low glucose Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 5% fetal bovine serum, 1% penicillin-streptomycin, and 2% 
glutamine (Invitrogen). Culture medium was changed every 48 hours and cells between 
passages 4 and 9 were used. Cells were seeded in 12 well plates at confluence in 2 ml 
complete medium and incubated at 37°C in a 5% CO2 incubator for 24 hours. For ROS 
measurement, cells were seeded at confluence in 2 ml complete medium in 35mm glass 
bottom dishes with a 14mm microwell diameter and 1.5 mm glass thickness for live cell 
confocal microscopy. Cells were incubated at 37°C in a 5% CO2 incubator for 24 hours. 
For each experiment, complete medium was replaced with the same medium 
supplemented with increasing concentrations of nanoparticles and incubated for an 
additional 24 hours. Negative control cells were incubated without nanoparticles, and 
positive control cells were incubated with 10 ng/ml tumor necrosis factor-α (TNFα). 
 
3.2.2 Nanoparticles 
Combustion synthesized nanoparticles or NanoArc magnetic iron oxide 
nanoparticles (Alfa Aesar, Ward Hill, MA) of 20-40 nm diameter were used in all 
experiments. 
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3.2.3 Live-Dead Assay for Cell Viability 
The Live-Dead assay (Molecular Probes) quantifies alive and dead cells by 
measuring intracellular esterase activity and plasma membrane integrity. Nonfluorescent 
dye Calcein AM converts to fluorescent calcein in the presence of intracellular esterase 
activity, producing a uniform green fluorescence in live cells. Ethidium homodimer-1 
enters cells with damaged membranes and binds to nucleic acids, producing red 
fluorescence in dead cells. 
For viability comparison between flame synthesized and commercially available 
iron oxide nanoparticles PAEC were seeded on sterile 13-mm round glass coverslips and 
cultured in 12-well tissue culture plates. After 24 hours, culture medium was replaced by 
medium with increasing nanoparticle concentrations. PAEC were incubated with 
nanoparticles for 24 hours, washed with phosphate-buffered saline (PBS), and treated 
with 150 μl solution of 2 μM calcein AM and 4 μM EthD-1 as per manufacturer 
instructions. Cells were incubated at room temperature for 45 minutes and viewed in an 
Olympus IX81 inverted fluorescent microscope. 
For assessing viability of magnetically labeled cells whose ROS formation was 
blocked, PAEC were seeded on 35mm glass bottom microwell dishes. After 24 hours, 
some samples were pre-incubated in 4 mM N-acetyl cysteine (NAC) to scavenge 
intracellular ROS and 50 mM sodium pyruvate to scavenge extracellular ROS for 2 
hours. PAEC were incubated with increasing concentrations of nanoparticles for 24 
hours, washed with phosphate-buffered saline (PBS), and treated with a 200 μl solution 
of 2 μM calcein AM and 4 μM ethidium homodimer-1 as per manufacturer instructions. 
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Cells were incubated at room temperature for 45 minutes and viewed in an Olympus 
IX81 inverted fluorescent microscope. 
 
3.2.4 Membrane Integrity Assay 
The CytoTox-ONE Homogenous membrane integrity assay kit (Promega, 
Madison,WI) measures release of lactate dehydrogenase (LDH) from cells with damaged 
membranes through the conversion of resazurin into fluorescent resorufin. PAEC seeded 
in 12-well tissue culture plates were incubated with nanoparticles as described 
previously. After 24 hours, 100 μl of medium from each sample was transferred into a 96 
well flat-bottomed black plate. 100 μl of CytoTox-ONE reagent was added to each well, 
after which the plate was incubated at room temperature for 10 minutes protected from 
light. Fluorescence was measured at 560/590 nm in a GENios microplate reader. 
 
3.2.5 Alamar Blue Cell Viability Test 
Alamar blue quantitatively measures cell proliferation and metabolic activity 
using an oxidation-reduction (REDOX) indicator that fluoresces and changes color in 
metabolically active cells. After 24 hours of nanoparticle exposure, 100 μl cell medium 
was transferred into 96 well flat-bottomed black assay plates. 10 μl Alamar blue solution 
(AbD Serotec Ltd, Oxford, UK) was added to each well and the well plate was incubated 
for 4h at 37°C in 5% CO2 atmosphere. Fluorescence was measured 535/590 nm in a 
GENios microplate reader. 
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3.2.6 Cell Proliferative Response to Fibroblast Growth Factor-2 
Fibroblast growth factor-2 (FGF-2) is heparin binding growth factor which 
induces proliferation and enhanced survival in endothelial cells, among other effects. 
PAEC were seeded in 6-well tissue culture plates. After 24 hours, medium was changed 
to medium supplemented with 0.1 mg/ml either purchased or synthesized iron oxide 
nanoparticles. Concurrently, 10 ng/ml FGF-2 was added to cells. Medium was changed 
and fresh FGF-2 added after 2 days. On days 3 and 5, 200μl Alamar blue (AbD Serotec 
Ltd, Oxford, UK) was added to each well. After 4 hours, 100 μl of medium, with Alamar 
blue from each sample was transferred into 96 well flat-bottomed black plates. 
Fluorescence was measured at 535/590 nm in a GENios microplate reader.  
 
3.2.7 Actin Cytoskeleton Labeling 
PAEC incubated with different concentrations of iron oxide nanoparticles were 
washed with PBS and fixed using 4% paraformaldehyde for 20 minutes. 0.1% v/v Triton 
X-100 in PBS was added to fixed cells for 5 minutes. After washing with PBS three times 
for 5 minutes, cells were blocked with 1% BSA in PBS for 30 minutes. To label the actin 
cytoskeleton, cells were incubated with 200 μL rhodamine phalloidin (1 unit/well) in 1% 
BSA for 20 minutes. To label the nuclei, cells were incubated with 200 μL Hoechst (bis-
benzimide, 1 μg/mL) in 1% BSA for 30 minutes. Cells were washed three times with 
PBS and stored at 4°C in PBS. Inverted coverslips were mounted on cover slides for 
confocal microscopy. Cell length was measured by measuring the distance between the 
66 
 
 
two sharp end points of the elongated cell. Cell length data in each condition is average 
of five individual cell length measurements.  
 
3.2.8 Reactive Oxygen Species Labeling 
Image iT Live Green Reactive Oxygen Species Detection Kit from Invitrogen was 
used for detection of ROS in live cells. The assay is based on 5-(and-6)-carboxy-2′,7′-
dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA), a reliable fluorogenic marker 
for ROS in live cells. It also uses cell-permeant nucleic acid stain Hoechst 33342 to label 
cell nuclei. The nonfluorescent carboxy-H2DCFDA permeates live cells and is 
deacetylated by nonspecific intracellular esterases. In the presence of nonspecific ROS 
produced throughout the cell, particularly during oxidative stress, the reduced fluorescein 
compound is oxidized and emits bright green fluorescence. Cells seeded on 35 mm glass 
bottom microwell dishes and incubated with different concentrations of iron oxide 
nanoparticles were labeled for ROS according to manufacturer’s protocol. Live cell 
imaging using an Olympus IX81 confocal microscope was performed with cells in 
HEPES buffer. Fluorescence intensity was measured with an emission wavelength of 495 
nm and excitation wavelength of 529 nm for Carboxy-H2DCFDA and with an emission 
wavelength of 350 nm and excitation wavelength of 461 nm for Hoechst. 
 
3.2.9 Scanning Electron Microscopy for Cell Morphology 
Scanning electron microscopy (SEM) was used to visualize nanoparticle 
interaction with cells. PAEC were seeded on 8 mm sterile glass coverslips in 12 well 
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plates and loaded with increasing nanoparticle concentrations as previously described. 
Cells were fixed in 3% glutaraldehyde (HMDS; EMS, Hatfield, PA) at room temperature 
for 20 minutes, rinsed three times with PBS for 5 minutes each, and dehydrated in graded 
ethanol (Pharmco, Brootfield, CT). Ethanol was then replaced with hexamethyldisilazane 
(EMS, Hatfield, PA), and samples were dried by overnight HMDS evaporation in a 
chemical fume hood. Samples were desiccated under vacuum for two days, sputter coated 
with 0.75 nm thick Pt/Pd layer to increase to increase conductivity, and viewed under a 
Zeiss Supra 50VP SEM. 
 
3.2.10 Transmission Electron Microscopy 
Samples for transmission electron microscopy (TEM) were fixed with 4% 
paraformaldyde overnight at 4°C.  The cells were washed with 0.1M cacodylate buffer 
prior to post fixation in 2% osmium tetroxide at room temperature.  After several 
additional buffer washes, the samples were dehydrated in a graded ethanol series prior to 
embedding in PolyBed 812 (Polysciences, Warrington, PA).  The cells were then 
sectioned en face, stained with uranyl acetate and bismuth subnitrite, and examined with 
a JEOL 1010 electron microscope fitted with a Hamamatsu digital camera and AMT 
Advantage image capturing software. 
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3.2.11 Statistical Analysis 
Samples were statistically compared using Student’s t-test. Statistical significance 
was established at either p<0.05 (#) or p<0.01 (*). Two-way ANOVA was used to 
compare changes over time, with statistical significance established at p<0.0001. 
 
 
3.3 Results 
3.3.1 Nanoparticle Synthesis and Analysis 
Two different size modes of iron oxide nanoparticles were synthesized using the 
flame synthesis method previously described in Chapter II. Iron pentacarbonyl, Fe(CO)5, 
was used as the liquid precursor and delivered to the reactor as saturated vapor carried by 
argon gas. All synthesis conditions were conducted under oxygen rich conditions with 
low equivalence ratios to minimize unwanted carbon contamination in synthesized 
nanoparticles. Inverse diffusion flame configuration, with oxidizer in the second annulus 
and fuel in the third annulus, resulted in a high concentration of magnetite formation as 
verified by Raman spectroscopy. For this reason, all iron oxide nanoparticles in this 
chapter were synthesized using the inverse diffusion flame configuration.   A table of 
operating conditions can be found in Table 2. 
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Table 2. The operating conditions were arranged to have an inverse diffusion flame with 
oxygen rich conditions in order to prevent unwanted carbon contamination and produce 
magnetite rich iron oxide nanoparticles. 
Precursor CH4 
[ml/min] 
O2 
[ml/min] 
Ar 
[ml/min] 
N2 
[ml/min] 
Equivalance 
Ratio [Ø] 
Fe(CO)5 494 3546 305 4000 0.28 
 
 
 
 
Representative TEM images of flame synthesized iron oxide nanoparticles 
collected at 5 cm above the burner exit are shown in Figure 12. Monodispersed iron oxide 
nanoparticles 6 – 12 nm in diameter (Figure 12A, B) were synthesized. In some cases, 
nanoparticle clusters formed due to excessive heat (Figure 12C). Significant Fe Kα, Fe 
Kβ, Fe Lα and O peaks were observed in the EDS spectrum (Figure 12D), confirming the 
iron and oxygen content of the nanoparticles. Since no significant C peak was observed, 
the high oxygen concentration of the flame successfully prevented unwanted carbon 
contamination. The copper Cu Kα and Cu Kβ peaks in EDS spectrum were background 
from the TEM grids. 
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Figure 12. TEM images of the flame synthesized iron oxide nanoparticles collected at 
5cm above the burner exit showed that monodispersed iron oxide nanoparticles 6 – 12 nm 
in diameter were synthesized (A, B). In some cases, nanoparticle clusters formed due to 
excessive heat (C). EDS analysis results of flame synthesized iron oxide nanoparticles 
verified the Fe and O composition of the nanoparticles with no carbon contamination (D). 
 
 
 
 
Raman spectroscopy of synthesized nanoparticles (Figure 13) indicated that the 
nanoparticles were a heterogenous mixture of two common forms of iron oxide, hematite 
and magnetite. For hematite, seven photon lines are expected in the Raman spectrum of 
two A1g modes and five Eg modes (225, 498, 247, 293, 299, 412 and 613 cm-1) [141]. 
Hematite is an antiferromagnetic material and the collective spin movement can be 
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excited in a magnon. The intense peak observed at 1320 cm-1 is assigned to a two-
magnon scattering which arises from interaction of two magnons created on antiparallel 
close spin sites [141]. For magnetite there are some disagreements in the literature for the 
locations of Raman peaks, especially for peaks very close to reported hematite peaks.  
Magnetite has five raman bands: three T2g, one Eg and one A1g (298, 320, 420, 530 and 
680 cm-1). But wide peaks observed at 320, 530 and 680 cm-1 are reported as the 
characteristic magnetite peaks in published studies [141]. The location of the raman 
peaks in literature [141] were also indicated in  Figure 13 for reference. 
 
 
 
 
 
Figure 13. Raman Spectrum of the flame synthesized iron oxide nanoparticles showed 
that nanoparticles synthesized were composed of two well known forms of iron oxide: 
magnetite, Fe3O4, and hematite, αFe2O3. The location of the raman peaks in literature [141] 
were also indicated for reference. 
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3.3.2 Nanoparticle Cellular Uptake 
Endothelial cells uptake flame synthesized superparamagnetic nanoparticles in a 
manner similar to commercially available nanoparticles. PAEC incubated with 0.1 mg/ml 
both commercially available and flame synthesized iron oxide nanoparticles uptake the 
nanoparticles inside (Figure 14A, C). No nanoparticles were observed in the cell nucleus 
and they were all located in the cell cytoplasm (Figure 14B, D).  
Scanning electron microscopy images of cell populations incubated with 
increasing concentrations of nanoparticles are shown in Figure 15. Endothelial cells 
remained attached and spread after 24 hours of exposure to 0.5 mg/ml nanoparticle 
solution. While no change in cell adhesion and total attached cell number was observed 
(Figure 15C, D, E, F, G, H), cell morphology did change with nanoparticle exposure. 
When incubated with nanoparticles (Figure 16C, D, E, F, G, H), endothelial cells were 
less spread, more rounded, and appeared to have lost their typical cobblestone 
morphology.  
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Figure 14. TEM images of the individual PAEC loaded with 0.1 mg/ml (A) commercially 
available and (C) combustion synthesized iron oxide nanoparticles showed that iron 
oxide nanoparticles were taken inside the cells. Both (B) commercially available and (D) 
combustion synthesized nanoparticles were not uptaken by cell nucleus and were located 
inside the cell cytoplasm as aggregated nanoparticle clusters.  
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Figure 15. SEM images of the cells loaded with different concentrations of purchased and 
synthesized iron oxide nanoparticles showed no significant difference in attached cell 
number and adhesion (C, D, E, F, G, H), however cell morphology did change with 
nanoparticle exposure. 
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Figure 16. Higher magnification SEM images of the individual cells loaded with different 
concentrations of purchased and synthesized iron oxide nanoparticles showed that when 
incubated with nanoparticles (C, D, E, F, G, H), endothelial cells were less spread, more 
rounded, and appeared to have lost their typical cobblestone morphology. 
 
76 
 
 
3.3.3 Nanoparticle Cytotoxicity 
Flame synthesized superparamagnetic nanoparticles demonstrate low cytotoxicity 
comparable to commercially available nanoparticles. Endothelial cell viability, as 
measured by the cell metabolic indicator Alamar blue, did not change with increasing 
nanoparticle concentration up to 0.1 mg/ml of iron oxide concentration. However at 
higher nanoparticle concentrations (0.5 mg/ml and 1.0 mg/ml), a decrease in cell 
metabolic activities was observed (Figure 17A). There was no statistically significant 
difference in cell viability with flame synthesized vs. commercially available 
nanoparticles. Endothelial cell membrane integrity, as measured by LDH release, 
demonstrated a slight loss of membrane integrity with purchased nanoparticles (Figure 
17B). However, no statistically significant changes in cell membrane integrity were 
observed in cells incubated with synthesized nanoparticles even at the highest iron oxide 
concentrations.    
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Figure 17. (A) Endothelial cell viability, as measured by the cell metabolic indicator 
Alamar blue, did not change with increasing nanoparticle concentration up to 0.1 mg/ml 
of iron oxide concentration. However at higher nanoparticle concentrations (0.5 mg/ml 
and 1.0 mg/ml), a decrease in cell metabolic activities was observed (A). Endothelial cell 
membrane integrity, as measured by LDH release, demonstrated a slight loss of 
membrane integrity with purchased nanoparticles (B). There was no statistically 
significant difference in cell viability and membrane integrity of the cells loaded with 
flame synthesized vs. commercially available nanoparticles. (# P<0.05 and * P<0.01 
relative to control cells) 
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Endothelial cell viability with both synthesized and purchased nanoparticles was 
confirmed using a Live/Dead cell viability assay. Fluorescent images of representative 
cell regions showed no observable difference in live and dead cell density (Figure 18B). 
When dead cell number was quantified using a microplate reader, samples loaded with 
high concentrations of both purchased and synthesized iron oxide nanoparticles showed 
slightly increased cell death over control cells (Figure 18A). However, there was no 
statistically significant change in cell death for the two types of nanoparticles.  
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Figure 18. Dead cell number quantified using a microplate reader showed slightly 
increased cell death in cells loaded with purchased and synthesized iron oxide 
nanoparticles over control cells (A). No statistical difference between the toxicity levels 
of PAEC loaded with different concentrations of commercially available and flame 
synthesized iron oxide nanoparticles was observed. 
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3.3.4 Endothelial Cell Proliferation with Internalized Nanoparticles 
PAEC nanoparticle exposure did not affect cell proliferation induced by FGF-2. 
PAEC with 0.1 mg/ml of either combustion synthesized or purchased nanoparticles 
showed increased proliferation by Alamar blue on the fifth day following cell seeding 
(Figure 19A). No statistically significant difference was observed in cell proliferation 
between cells exposed to combustion synthesized nanoparticles or commercially 
available nanoparticles. Phase contrast images confirmed that cells exposed to 
nanoparticles respond to FGF-2 in a similar manner to control cells in terms of cell 
morphology. While cells not stimulated by FGF-2 exhibited a typical cobblestone 
architecture, cells stimulated with 10 ng/ml FGF-2 became elongated and formed 
swirling patterns independent of nanoparticle concentration or source (Figure 19B). 
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Figure 19. PAEC loaded with 0.1 mg/ml of synthesized and purchased iron oxide 
nanoparticles showed an increase in cell proliferation in the presence of FGF-2 by 
Alamar blue assay (A), and responded to FGF-2 by becoming elongated and forming 
swirling patterns (B). (* P<0.01 relative to w/o FGF-2 condition) 
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3.3.5 Effect of Nanoparticle Concentration on ROS Formation  
Nanoparticles inside PAEC increased intracellular ROS formation over time. 
Cells loaded with 0.5 mg/ml iron oxide nanoparticles started to show an increased ROS 
after 1 hour. We observed a 480% increase in ROS formation at 2 hours, and an 820% 
increase in ROS formation at 3 hours (Figure 20A). No additional increase in ROS 
formation was observed after 4 hours. Confocal images show increase in green 
fluorescence signal intensity from Carboxy-H2DCFDA (Figure 20C). ROS formation also 
increased with increasing iron oxide concentration. PAEC loaded with 0.1, 0.5 and 1.0 
mg/ml iron oxide nanoparticles had 100%, 250% and 350% more ROS inside the cell 
cytoplasm, respectively (Figure 20B).  
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Figure 20. Nanoparticles increased cellular ROS formation. (A) ROS formation increases 
with time of nanoparticle exposure. (B) ROS formation increased with increasing iron 
oxide concentration. (C) Intensity of the green fluorescence signal from Carboxy-
H2DCFDA increases up to 3 hours. Scale bar is 100µm.  
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3.3.6 Actin Cytoskeleton Elongation with Increasing Nanoparticle Concentration and 
Over Time  
 
Actin cytoskeleton disruption was observed when cells were loaded with 0.01, 
0.05, 0.1, 0.5 and 1.0 mg/ml iron oxide nanoparticles (Figure 21A). As nanoparticle 
concentration increased, cells and actin stress fibers elongated. Cells loaded with 0.5 
mg/ml iron oxide nanoparticles elongated approximately 140% and cells loaded with 1.0 
mg/ml iron oxide nanoparticles elongated 153%. The average cell length increased from 
32 µm for control cells to approximately 77 µm and 81 µm for cells loaded with 0.5 
mg/ml and 1.0 mg/ml iron oxide nanoparticles, respectively. Confocal images show the 
increase in cell length with increasing nanoparticle concentration (Figure 21C). Actin 
fiber elongation also increased over time. PAEC loaded with 0.5 mg/ml iron oxide 
nanoparticles did not show an increase in actin length for the first 4 hours. Average actin 
fiber length increased 44%, 88%, and 122% at 6, 8, and 12 hours respectively compared 
to control cells (Figure 21B). After 12 hours, no additional increase in actin length was 
observed. 
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Figure 21. Nanoparticles disrupted the actin cytoskeleton. (A) Cell length increased when 
PAEC were loaded with iron oxide nanoparticles. (B) Actin cytoskeleton elongation 
occured between 4 and 12 hours. (C) Confocal images show the cell and actin elongation. 
Cells lost their cobblestone morphology and become elongated when loaded with iron 
oxide nanoparticles. (n=3, # p < 0.05 relative to ctrl sample) 
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3.3.7 Effect of ROS Blockers on ROS Formation and Actin Cytoskeleton Elongation 
PAEC were loaded with 0.5 mg/ml iron oxide nanoparticles and ROS production 
was prevented by adding 4 mM N-acetyl cysteine (NAC) and 50 mM sodium pyruvate. 
For samples where ROS formation was blocked, no change in actin length was observed. 
This suggests that blocking ROS production blocks actin cyctoskeleton disruption. When 
ROS formation was induced by tert-butyl hydroperoxide (TBHP) as a positive control, a 
45% increase in actin length was observed with respect to control cells (Figure 22A). 
NAC and sodium pyruvate did effectively reduce ROS formation (Figure 22B). A 32% 
and 35% decrease in ROS formation was observed in cells loaded with 1 mg/ml iron 
oxide nanoparticles when NAC or sodium pyruvate were added (Figure 22B). Confocal 
images also showed that PAEC loaded with nanoparticles became less spread and 
elongated, while magnetically labeled cells whose ROS formation was blocked kept their 
original cobblestone morphology (Figure 22C). 
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Figure 22. NAC and sodium pyruvate blocked ROS formation, which blocked actin 
disruption. (A) Actin fibers did not elongate in cells loaded with 0.5 mg/ml nanoparticles 
when ROS formation was blocked with NAC and sodium pyruvate. (B) In PAEC loaded 
with 1 mg/ml iron oxide nanoparticles, NAC and sodium pyruvate decreased ROS 
formation. (C) Confocal images showed that while PAEC loaded with nanoparticles 
elongated, magnetically labeled cells whose ROS formation was blocked kept their 
original cobblestone morphology. (n=3, # p < 0.05, relative to ctrl sample) 
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3.3.8 ROS Blockers Effect on Cell Viability 
A Live/Dead assay showed that ROS blockers NAC and sodium pyruvate 
decreased nanoparticle-induced cell death. 0, 0.1 and 0.5 mg/ml iron oxide nanoparticles 
did not significantly change cell viability (Figure 23A). However in PAEC loaded with 
1.0 mg/ml iron oxide nanoparticles, NAC and sodium pyruvate blocked 66% and 50% of 
the cell death respectively. Fluorescent images represent live and dead cells labeled with 
Live/Dead assay dyes (Figure 23B).  
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Figure 23. ROS blockers NAC and sodium pyruvate reduced cell death due to 1.0 mg/ml 
iron oxide nanoparticles. (A) PAEC loaded with 1.0 mg/ml iron oxide nanoparticles 
showed increased cell death, which was reduced by NAC and sodium pyruvate. (B) 
Fluorescent images representing the live (green) and dead (red) cells in each condition. 
Scale bar is 100µm. 
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3.4 Discussion 
We demonstrated that combustion synthesis can produce superparamagnetic iron 
oxide nanoparticles 6 – 12 nm in diameter, and that these nanoparticles are equally 
biocompatible as commercially available nanoparticles. Combustion synthesis provides 
significant advantages over other material synthesis processes, including controllable 
particle size, size distribution, phase and composition. This method is further capable of 
commercial production rates with minimal post-processing of the final product materials. 
We further showed that uptake of iron oxide nanoparticles in PAEC results in a dose 
dependent increase in ROS formation in cells which also induces actin cytoskeleton 
disruption. The investigation of underlying mechanisms that result in nanoparticle 
toxicity in cells is crucial since if one could block the mechanisms which result in cellular 
toxicity, it might be possible to use nanoparticles in various biomedical applications 
without further worrying about the toxicity issues.  
The experimental conditions for iron oxide nanoparticle combustion synthesis 
were selected to obtain small size nanoparticles with high magnetite content. An inverse 
diffusion flame configuration, where oxidizer flows through the second annulus and fuel 
flows through the third annulus, was selected over a diffusion flame configuration, where 
fuel flows through the second annulus and oxidizer flows through the third annulus. In 
the diffusion flame configuration, the precursor first reacts with the fuel, creating a flame 
at the center of the second ring. This process generates larger particles, as the 
concentrated Fe(CO)5 precursor  experiences higher temperatures. In the inverse diffusion 
flame configuration, the precursor is diluted by the oxidizer before reaching the fuel, 
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resulting in smaller particle sizes compared to the diffusion flame configuration. This 
phenomenon has previously been described by Pratsinis et al. [139] for TiO2 formation at 
different gas mixing conditions.  
A common challenge in combustion synthesis is carbon contamination. In this 
study, carbon contamination was reduced by producing nanoparticles in oxygen rich 
conditions. An equivalence ratio (ratio of the actual fuel/air ratio to the stoichiometric 
fuel/air ratio) of 0.28, prevented carbon contamination, as seen from the lack of carbon 
peak in EDS studies (Figure 12D). However, the oxygen rich environment raised flame 
temperature, which would have increased nanoparticle size and decreased magnetite 
content. This was prevented by flowing an N2 stream through the third annulus along 
with CH4 to cool down the flame temperature. 
Nanoparticle size is critical to magnetic properties. Magnetite particles less than 
20 nm in diameter exhibit superparamagnetism [163]. Despite the increase in 
superparamagnetism with decreased nanoparticle size, nanoparticles with diameters less 
than 10 nm have lower saturation magnetization values [164, 165]. For a 
superparamagnetic particle with magnetic moment ( )Vm 0µχβ= , the minimum particle 
size that can be attracted to field maxima is 2023 βµβTkV = , where V β , βk , χ , 0µ ,T  
are the particle volume, magnetic field, Boltzmann constant, magnetic susceptibility, free 
space permeability, and absolute temperature (Kelvin), respectively [166]. In other 
words, to move a smaller particle, a higher magnetic field must be provided. 
Nanoparticle size is also critical to body tissue distribution. Nanoparticles smaller 
than 100 nm are internalized in cells, but contrary to intuition, smaller size nanoparticles 
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do not necessarily have better cellular uptake. For instance HeLa cells show a tendency to 
uptake 50 nm gold particles over any other size [167], and MCF-7 breast cancer cells 
uptake 100 nm gold nanoparticles most efficiently [168]. Nanoparticles of less than 10 
nm diameter are removed from blood circulation through renal clearance and 
extravasation [4]. On the other hand, particles with more than 200 nm in size have low 
blood circulation times because they are isolated by the spleen and removed by 
phagocytosis [4]. 
We produced 6 – 12 nm diameter monodispersed nanoparticles, as well as 
nanoparticle aggregates of less than 100 nm in size (Figure 12). When nanoparticles were 
sampled at the burner exit, they were monodispersed. As the nanoparticles advanced in 
the flame, they began to form aggregates due to the high heat [44].  Sonication can break 
up these aggregates [169], however synthesis of aggregates of individual 6 – 12 nm 
superparamagnetic nanoparticles with total cluster sizes of less than 100 nm might make 
it easier to attract and move these nanoparticles under a magnetic field while still keeping 
them in the blood circulation. 
 Endothelial cells loaded with nanoparticles attached, adhered and spread on 
surfaces, which is critical to function of these attachment-dependent cells [170, 171]. It 
has been previously verified by TEM analysis that iron oxide nanoparticles are 
internalized by human fibroblast cells [171] and mouse breast cancer cells [69]. Our TEM 
images also showed that iron oxide nanoparticles were internalized in PAEC and formed 
nanoparticle aggregates in cell cytoplasm. We showed similar representation of 
internalized nanoparticles in our SEM images of PAEC loaded with purchased and flame 
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synthesized iron oxide nanoparticles, and we verified that the observed cell protrusions 
were iron oxide by EDS. While purchased and synthesized nanoparticles did not alter cell 
viability at low iron oxide nanoparticle concentrations, cell attachment profile and 
morphology began to change at higher iron oxide concentrations (0.5 mg/ml). It is likely 
that these endothelial cells would die and detach if incubated with high nanoparticle 
concentrations for longer periods of time. 
In the present study, the toxic effect of a wide range of nanoparticle 
concentrations was investigated. Since the nanoparticle concentrations to which 
endothelial cells are exposed in vivo is yet to be determined, we believe this data will 
elucidate toxicity-concentration relationships for a wide variety of applications. Our 
toxicity tests revealed that iron oxide nanoparticles show little cytotoxicity up to a 
concentration of 0.1 mg/ml. Most importantly, there was no significant difference 
between in cytotoxicity of cells loaded with commercially available nanoparticles and 
combustion synthesized nanoparticles. A slight increase in cell death and membrane 
damage was observed at the higher nanoparticle concentrations of 0.5 mg/ml and 1.0 
mg/ml by Live/Dead and LDH assays.  
However a significant decrease in Alamar blue fluorescence was observed at 
nanoparticle concentrations of 0.5 mg/ml and 1.0 mg/ml. Two reasons might account for 
the difference between the Alamar blue assay and the Live/Dead and LDH assays. First, 
nanoparticles in the medium might interfere with Alamar blue fluorescence. Upon 
investigation, we found nanoparticles did affect Alamar blue fluorescence, especially at 
higher nanoparticle concentrations, but the effect did not alter the overall trend. We 
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compensated for the nanoparticle effect by normalizing Alamar blue fluorescence with 
controls consisting of medium with nanoparticles not exposed to cells. In general, the 
Alamar blue assay data should be compensated for nanoparticles in the medium and 
confirmed through other toxicity and metabolic activity tests. 
Even controlling for the effect of nanoparticles on Alamar blue fluorescence, the 
fluorescence still decreased as nanoparticle concentration increased. Alamar blue 
measures cell metabolic activity, which often correlates with cell viability. It is possible 
that endothelial cells exposed to high nanoparticle concentrations (0.5 mg/ml and 1.0 
mg/ml) have a lower metabolic rate, even if cell death does not occur. We hypothesize 
that the increase in nanoparticle concentration, both purchased and synthesized, slightly 
increased cell death, however it did decrease cell metabolic activities significantly at high 
iron oxide nanoparticle concentrations. 
Endothelial cell functions beyond survival and metabolic activity are critical for 
nanoparticles that are functionalized to promote or inhibit a specific cellular process. 
Nanoparticles could be used to either enhance or inhibit endothelial-cell dependent 
angiogenesis, the growth of new blood vessels from existing vessels. Stimulating 
angiogenesis could aid in tissue engineering and wound repair, whereas inhibiting 
angiogenesis could treat diseases such as arthritis, diabetes and cancer [172]. 
Nanoparticles are extensively used in tumor therapy since tumors have a selective and 
faster nanoparticle uptake than healthy tissue [173]. Under an oscillating magnetic field, 
magnetic nanoparticles inside the tumor cells heat up to 43-45°C and destroy cancer cells 
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[82-85]. But there is no data in the literature showing the effect of nanoparticle presence 
inside the healthy or malignant cells on cell proliferation. 
FGF-2 is a potent growth, survival and differentiation factor that also plays a 
critical role in guiding endothelial cells in the angiogenic process [174, 175]. We now 
show that nanoparticles do not affect cell proliferation in response to a growth factor. 
Endothelial cells loaded with a low concentration of either synthesized or purchased 
nanoparticles and stimulated by FGF-2 proliferated in similar manner to control cells. 
These findings showed that the two types of nanoparticles are not only not toxic to the 
PAEC up to a certain concentration, but also they do not change the reaction of the cells 
to certain signaling molecules and stimuli like growth factors. These data demonstrate the 
feasibility of using magnetic nanoparticles to induce cell proliferation. 
Nanoparticles may interfere with biological functions or induce cytotoxicity in 
several different ways. The chemical composition of some nanoparticles can be toxic. For 
instance, silver nanoparticles were shown to be more toxic than other metal oxide 
nanoparticles in rat liver cells due to hypothesized reactive oxygen species generation 
[176]. The nanoparticle chemical and physical properties, such as particle size and 
surface coating material, might change the cellular response to nanomaterial uptake. 
Gupta and Gupta [4] reported that modifying the surface of superparamagnetic iron oxide 
nanoparticles with pullulan, a nonionic polysaccharide, reduced nanoparticle cytotoxicity 
in human fibroblasts. In addition, there might be effects caused by the nanoparticle shape 
and the interaction manner between cells and particles themselves. For instance, it has 
been reported that carbon nanotubes can pierce cells like needles [177]. 
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We showed that nanoparticle localization in the cell cytoplasm resulted in defects 
and disruptions in the cellular cytoskeleton, primarily actin fibers.  The actin cytoskeleton 
is a highly dynamic network composed of actin polymers and a variety of associated 
proteins that mediate essential biological functions in cells, including intra and 
extracellular movement and structural support. The actin cytoskeleton rapidly changes 
shape and organization in response to stimuli and cell cycle progression. Therefore 
orientational disribution of actin filaments within a cell is an important determinant of 
cellular shape and motility. The cytoskeleton is sensitive to ROS formation and oxidative 
stress due to the presence of thiol groups on the actin microfilaments [178]. On oxidation, 
these filaments cross-link, leading to reduced cell motility. In this study we showed that 
there was an internalization and dose-dependent increase in actin cytoskeletal stress fiber 
formation following treatment of PAEC with superparamagnetic nanoparticles. 
Small particle volume and large surface area makes nanoparticles unique from 
their bulk counterparts, which may result in direct interaction of atoms and molecules on 
the particle surface with cellular organelles [113]. A major mechanism for nanoparticle 
toxic effects is related to nanoparticle-induced oxidant stress response [179].While at low 
levels, ROS are involved in regulating normal cell functions, at higher abnormal levels, 
ROS result in cell injury and death [180]. In this study, it was found that the exposure to 
iron nanoparticles induces the ROS production in PAEC. Furthermore, we found that 
ROS levels increase with nanoparticle concentration. We observed an increase in ROS 
formation up to an iron oxide concentration of 1.0 mg/ml. When we further increased the 
iron oxide concentration to 2.0 mg/ml and 3.0 mg/ml, we did not observe a further 
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increase in ROS (data not shown). We believe that this is because cells are saturated with 
nanoparticles after 1.0 mg/ml and do not take any additional nanoparticles in. High iron 
oxide nanoparticle concentrations also cover most of the cell surface and blocks the 
fluorescence generated in the cells due to the ROS formation. 
We also showed that cellular ROS level increased in the first 3 hours after 
nanoparticle exposure, but no additional increase was observed after 4 hours. This 
suggests that the main nanoparticle uptake occurs in the first 3 hours and then cells 
saturate and do not take up any more nanoparticles. Data in literature also verifies this 
nanoparticle saturation effect. HeLa cells and mouse macrophages took up ionic 
maghemite nanoparticles for the first 3 hours, and then nanoparticle uptake saturated 
[58]. 
NAC and sodium pyruvate are intracellular and extracellular ROS scavengers 
respectively. We observed a decrease in ROS formation in magnetically labeled cells 
whose ROS production was blocked. Our initial hypothesis was that nanoparticle toxicity 
was related to ROS formation inside cells. From our previous studies, 1.0 mg/ml iron 
oxide nanoparticles resulted in a decrease in cell metabolic activities and viability [181]. 
If the scavengers blocked ROS formation, we expected to observe a decrease in dead cell 
number in cells loaded with 1.0 mg/ml iron oxide nanoparticles. Our studies showed that 
ROS scavengers successfully decreased cell death with 1.0 mg/ml iron oxide 
nanoparticles, verifying that ROS are a major mechanism of nanoparticle toxicity.  
Actin cytoskeleton disruption occurred between 4-12 hours after nanoparticle 
loading, while ROS formation occurred 1 hour after nanoparticle loading. This suggests 
98 
 
 
that ROS formation first occurs in the cell, and then it mediates actin cytoskeleton 
disruption. If ROS formation is prevented, a decrease in actin cytoskeleton disruption is 
expected. When ROS formation was blocked, PAEC labeled with nanoparticles still 
showed disrupted actin cytoskeleton but the disruption was much smaller than samples 
without blocked ROS. This suggests that ROS formation and actin cytoskeleton 
disruption works in a coupled manner, with ROS formation triggering actin cytoskeleton 
disruption. 
In this study, nanoparticle cytotoxicity was assessed by incubating combustion 
synthesized and commercially available iron oxide nanoparticles with endothelial cells. 
Cells exposed to both types of nanoparticles attached to surfaces, remained viable and 
maintained membrane integrity up to 0.1 mg/ml of nanoparticle concentration. However, 
cell metabolic activity decreased significantly at high iron oxide nanoparticle 
concentrations. In all cytotoxicity assays, no significant toxicity difference was observed 
between combustion synthesized and commercially available nanoparticles. Neither 
nanoparticle type affected cell proliferation induced by FGF-2, as long as the 
nanoparticle concentration was low.  
These data suggest that combustion synthesized iron oxide nanoparticles are 
comparable to commercially available nanoparticles for biological applications. 
Combustion synthesis is a relatively simple synthesis process with higher purity products 
and lower time and energy manufacturing costs. It also shows that when iron oxide 
nanoparticles were uptaken by PAEC cells they localized inside the cell cytoplasm as 
aggregated clusters. Nanoparticle uptake increased ROS formation in cells during the first 
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three hours after the uptake. ROS formation induced actin cytoskeleton disruption, and 
actin fibers started to elongate after addition of ROS blockers to the PAEC also blocked 
the actin cytoskeleton elongation, pointing to a coupled reaction between ROS formation 
and actin cytoskeleton disruption. Future work will include coating and functionalizing 
nanoparticle surfaces for biological applications, including specific cell targeting and 
bioactive factor delivery and investigation of the ROS formation and actin cytoskeleton 
disruption under shear stress conditions. 
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CHAPTER IV:BIOPRINTED NANOPARTICLES FOR TISSUE ENGINEERING 
APPLICATIONS 
 
 
4.1 Introduction 
Tissue engineering is an interdisciplinary field that uses engineering and life 
science principles to advance our knowledge of tissue growth, which is then applied 
toward the development of biological tissue substitutes to restore organ function [96]. 
Tissue engineering may require precise patterning of cells and bioactive components to 
recreate the complex, three-dimensional architecture of native tissue. These cells and 
bioactive factors may then need to be repositioned during tissue growth in vitro or after 
implantation in vivo to achieve the desired tissue properties. Certain biological 
components that are valuable in tissue development, such as stem cells or growth factors 
or nanoparticles themselves, may induce unwanted effects when the tissue engineered 
construct is implanted. It may be beneficial to remove these cells and bioactive 
components entirely prior to implantation for biosafety concerns. Furthermore, it is 
difficult to noninvasively image and track cells and bioactive factors once they are 
incorporated into the tissue engineered construct, much less when they are implanted in 
vivo. Visualization of how the tissue components move and interact is critical to 
improving our understanding of tissue development. 
Many biofabrication techniques have been developed to incorporate living cells 
into functionalized scaffolds in a reproducible, three-dimensional pattern [98, 99]. Rapid 
prototyping [102, 103], inkjet-based cell printing [104-106], and microcontact printing 
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[107, 108] are among the commonly used cell deposition systems for tissue engineering 
applications. These biofabrication methods allow initial deposition of scaffold and cells 
in a pre-defined pattern. However, the methods are often expensive, time consuming, 
require chemically modified surfaces, or cause cell damage due to high temperatures and 
pressures used in the deposition process. We developed a direct cell writing system for 
the freeform construction of biopolymer-based three-dimensional tissue scaffolds and 
cell-embedded tissue constructs [109]. The direct cell writing system uses micronozzles 
driven by pneumatic microvalves to deposit living cells, scaffold material, and bioactive 
components such as growth factors in controlled amounts with precise spatial positioning. 
The system requires no pre-processing, is computer controlled to rapidly produce sample 
replicates, and operates at room temperature and low pressure to maximize cell viability.  
Recently, several new approaches have been proposed to actively pattern cell 
constructs using external forces, including dielectrophoresis [182], an optical trap [183], 
or superparamagnetic nanoparticles in a magnetic field [184, 185]. Superparamagnetic 
iron oxide nanoparticles have been of primary interest for both in vivo and in vitro 
applications because they exhibit magnetic behavior only in the presence of a magnetic 
field [4]. These nanoparticles can be conjugated with proteins or loaded inside cells, are 
relatively non-toxic, and can be imaged by magnetic resonance imaging (MRI) or 
computed tomography (CT). In vivo, superparamagnetic nanoparticles have been used to 
target drugs to a treatment site to increase drug efficiency and reduce systemic effects 
[56]; to enhance gene delivery to target cells since nanoparticles easily cross cell 
membranes [90, 91]; and to detect vascular tissues such as tumors, since iron oxide 
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nanoparticles appear dark on MRI images [77, 78]. In vitro, superparamagnetic 
nanoparticles have been used to create high resolution, two-dimensional cell patterns on 
non-functionalized surfaces [184]. More recently, Frasca et al. used magnetic fields and 
magnetic field gradients to achieve three dimensional cell patterning [185]. However the 
ability of this technique to create complex three-dimensional shapes is highly limited 
since the only method of shape control is with a magnetic field gradient from magnets 
placed under the scaffold material. 
We combined the initial patterning capabilities of the direct cell writing system 
with the active patterning capabilities of superparamagnetic nanoparticles. This new 
hybrid technique allows biofabrication of a complex three-dimensional tissue scaffold of 
magnetically labeled cells and bioactive factors, which could then be manipulated and 
tracked within the tissue engineering construct. We further assessed the role of the 
biofabrication conditions in nano-bioprinting system efficacy.  Specifically, we 
investigated the effect of printing parameters and scaffold biopolymer properties on cell 
viability, nanoparticle manipulation, and patterning capabilities.  
Two primary printing parameters in cell writing systems are nozzle diameter and 
printing pressure. During printing, cells are exposed to shear stress several orders of 
magnitude higher than shear stress experienced in vivo  [186]. These mechanical forces 
may alter cell function, and in extreme cases, compromise cell viability [187]. For direct 
cell writing systems, both decreasing nozzle diameter and increasing dispensing pressure 
increase mechanical stresses and decrease cell viability after printing [110, 188]. 
Nanoparticles, either in the scaffold polymer or in the cells, may accentuate these 
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mechanical effects on cells. Printing resolution is also affected by nozzle diameter and 
printing pressure. Changes in biopolymer flow rate, printed line width, and pattern 
precision can alter important scaffold parameters, including porosity and elastic modulus 
[189-192].   
The scaffold biopolymer properties impact the nano-bioprinting system by 
influencing nanoparticle manipulation after printing and printing resolution. Nanoparticle 
movement within a viscous material is a balance between the magnetic force that drives 
movement and the viscous drag that opposes movement [193]. Thus biopolymer 
viscosity, and any nanoparticle effects on biopolymer viscosity, may impact post-printing 
manipulation of cells and bioactive factors. The biopolymer viscosity, with and without 
nanoparticles, may also affect printing resolution. Previous studies with collagen, 
chitosan, and alginate scaffolds have shown that biopolymer viscosity is a function of 
shear rate, viscosity increases with biopolymer concentration, and cells may increase 
biopolymer viscosity [194]. Viscosity changes, including non-Newtonian effects, can 
change printed line width and dramatically affect printing of defined three-dimensional 
structures [189, 194, 195]. 
In this study, we initially hypothesized that combining of solid freeform 
fabrication system with magnetic nanoparticles would allow movement and imaging of 
cells and bioactive factors within three dimensional tissue scaffolds. Superparamagnetic 
iron oxide nanoparticles were bioprinted either in an alginate scaffold or inside 
endothelial cells using the multinozzle direct cell writing system. Cell viability was 
assessed for various nanoparticle and alginate concentrations at varied nozzle sizes and 
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printing pressures for cells printed either with nanoparticles in the alginate scaffold 
polymer or with nanoparticles in cells. The effect of cell dispensing parameters and 
scaffold biopolymer characteristics on cell viability, nanoparticle movement, and 
bioprinting patterning capabilities was evaluated. Nanoparticles in both alginate and 
endothelial cells were manipulated using a magnetic field. The influence of nanoparticles 
on alginate scaffold viscosity, as well as the effect of alginate viscosity on nanoparticle 
movement, was quantified. Lines and patterns were printed with and without 
nanoparticles in the alginate, and bioprinting resolution was measured. Finally, 
nanoparticles were patterned inside three dimensional biopolymer scaffolds and imaged 
using a Micro Computed Tomography (MicroCT) scanner. Bioprinting of 
superparamagnetic iron oxide nanoparticles could help create more versatile tissue 
engineering structures, as well as improve our understanding of cell behavior in three 
dimensional tissue culture. We now show that the hybrid nano-bioprinting system 
performs as well as the existing bioprinting system, but that nanoparticle manipulation is 
highly dependent on scaffold viscosity.   
 
 
4.2 Materials and Methods 
4.2.1 Chemical Formulation 
Sodium alginate powder (FMCBioPolymer, Drammen, Norway) was dissolved in 
deionized water at 0.5, 1, 2 and 3% w/v concentrations. An ionic cross-linking solution 
was prepared by dissolving calcium chloride, CaCl2 (BDH Chemicals, Poole, UK), in 
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deionized water. NanoArc magnetic iron oxide nanoparticles (Alfa Aesar, Ward Hill, 
MA) of 20-40 nm diameter were used in all experiments. Spherical nanoparticles of the 
given size were selected to obtain maximum uptake efficiency [196].  Sodium alginate-
magnetic nanoparticle solutions were prepared by vigorously mixing sodium alginate 
with increasing concentrations of iron oxide nanoparticles to achieve a homogeneous 
nanoparticle distribution. 
 
4.2.2 Cell Culture 
Porcine aortic endothelial cells (PAEC) were isolated and cultured as previously 
described. Prior to printing, cells were gently mixed at a concentration of 1.5 x 105 
cells/ml in sodium alginate solution to ensure uniform cell distribution. For magnetically 
labeled cells, PAEC in 100 mm tissue culture dishes were loaded with different 
nanoparticle concentrations and incubated at 37°C in a 5% CO2 incubator for 24 hours. 
Cell nanoparticle uptake was confirmed by TEM. Our TEM images also suggest that the 
majority if not all cells take up nanoparticles. 
 
4.2.3 Cell Dispensing System 
A proprietary solid freeform fabrication–based direct cell writing system (Figure 
24A) was developed to create three-dimensional tissue constructs by dispensing cells and 
biopolymers into predefined patterns [109, 110]. The direct cell writing system used in 
this study operates at room temperature and low-pressure conditions to facilitate 
deposition of living cells, growth factors, or other bioactive compounds in controlled 
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amounts with precise spatial positioning. Pneumatic microvalves (EFD, East Providence, 
RI) were used to apply printing pressures of 2, 5 and 40 psi [109, 110] (Figure 24B). 
Sodium alginate was chosen as the scaffold biopolymer. Alginate-nanoparticle-
cell mixtures with 0, 0.1, or 1.0 mg/ml nanoparticle concentration were printed with 410 
and 250 µm nozzles. Control samples were dispensed in the system but without using 
nozzle tips. All samples were dispensed as 0.3 g of bulk material with a sample size of 
three, and each experiment was repeated a minimum of two times. Data presented are 
from one representative experiment. After dispensing, each sample was immediately 
submerged in a 5.0% w/v CaCl2 cross-linking solution for 5 min, placed in supplemented 
medium, and returned to the incubator. Samples in the long-term study were cross-linked 
daily to maintain both cell immobilization and alginate structural integrity. 
Representative images of printed bulk samples and cell distribution in alginate bulk 
samples are presented in Figure 24C, D, E. 
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Figure 24. (A) Schematic of solid freeform fabrication-based cell writing system. 
(Reproduced from Fig. 1 of Chang et al (23).) (B) Pneumatic microvalve with nozzle tip 
printing pattern of nanoparticles mixed in alginate. (C) Printed bulk samples used for cell 
viability tests. (D) PAEC homogenously distributed in CaCl2 crosslinked alginate. (E) 
Magnetically labeled PAEC homogenously distributed in alginate. 
 
 
 
 4.2.4 Cell Viability 
Alamar blue quantitatively measures cell metabolic activity using an oxidation-
reduction (REDOX) indicator that fluoresces and changes color in metabolically active 
cells [197]. Cross-linked alginate-cell solutions in 6 well plates were incubated with 2 ml 
supplemented medium and 200 μl Alamar blue solution (AbD Serotec Ltd, Oxford, UK). 
After 4 hours of incubation at  37°C in 5% CO2 atmosphere, 100 μl of medium from each 
well was transferred into a 96 well flat-bottomed black assay plate, and fluorescence was 
measured at 535/590 nm in a GENios microplate reader. 3 x 104 cells were calibrated to a 
fluorescence intensity reading of 35000. Since the Alamar blue assay measures the mean 
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metabolic activity of the cell population, cell viability was confirmed using a Live/Dead 
assay (Invitrogen, Carlsbad, CA) as per manufacturer instructions. 
 
4.2.5 Nanoparticle and Magnetically Labeled Cell Movement in the Scaffold  
Bulk samples of 1.0 mg/ml magnetic nanoparticles in 0.5, 1.0 and 2% w/v 
alginate were printed using the direct cell writing system. A 1 inch diameter NdFeB 
magnet with a surface field of 6450 Gauss (K&J Magnetics, Jamison, PA) was placed 
under the 60 mm cell culture dishes. Specific patterns of nanoparticles and magnetically 
labeled cells were also printed using the cell dispensing system. A rectangular NdFeB 
magnet with a surface field of 6450 Gauss (K&J Magnetics, Jamison, PA) was used to 
move nanoparticles to a specified location either in a new pattern or while maintaining 
the original printed pattern. Movement of magnetic nanoparticles and the magnetically 
labeled cells by the applied magnetic field was imaged using a 4 Megapixel CCD camera 
(Alpha Innotech, San Leandro, CA).  
 
4.2.6 Mathematical Evaluation of the Nanoparticle Movement  
1.0 mg/ml magnetic nanoparticles in 1% or 2% w/v alginate were printed using 
the direct cell writing system at a fixed location (x = 2mm) from a 1 inch diameter 
NdFeB magnet (K&J Magnetics, Jamison, PA) (Figure 25A).  Nanoparticle displacement 
along the magnet center line was imaged at 100 frames/second using a Nikon TS100 
microscope. Nanoparticle velocity was calculated from the derivative of the transient 
displacement data. 
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Figure 25. (A) Experimental setup for tracking nanoparticle movement in alginate. (B) 
Magnetic field along the magnet center axis increases nearer to the magnet pole. 
 
 
 
 
 
Experimental nanoparticle velocity observations were compared to theoretical 
calculations. The net force induced on a superparamagnetic nanoparticle in a viscous 
medium by an externally applied magnetic field gradient is a balance of the magnetic 
force (Fmag) and the viscous drag (Fvisc) [198, 199]: 
                                                                                                  (2) 
                                          (3) 
where   is the total nanoparticle magnetic moment, which depends on the nanoparticle 
material and volume;  is the magnetic field;  is the suspending fluid viscosity;  is the 
nanoparticle diameter; and  is the instantaneous nanoparticle velocity. For a one-
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dimensional problem along the magnet centerline (x axis), the nanoparticle velocity  at 
steady state can be obtained by balancing the forces from equations (2) and (3) as: 
                                                                                                  (4)    
where   is the particle saturation magnetization and  is the magnetic field 
gradient along the center axis.   
The field intensity was calculated along the center axis(x) of the cylindrical 
magnet using the following analytical expression [200]: 
                                                            (5) 
where  is the flux density at a point  away from the pole face and parallel to the magnet 
axis,  is the magnet length, and is the magnet radius.  Note that the flux direction is 
normal to the pole surface along the axis.  The residual induction of the permanent 
magnet is  and is a characteristic of the magnet material.  The magnetic flux density 
derivative,   was calculated as: 
 (6)             
Theoretical calculations were compared with experimental results by substituting 
appropriate materials properties for the magnet and nanoparticles used. The NdFeB had 
magnetic flux density = 14800 G, radius r = 25.4 mm, and length l = 12.7 mm.  
Magnetic field along the center axis of the magnet reached a maximum of 5200 G near 
the pole and decreased to 4400 G 2mm away from the magnet (Figure 25B).  Saturation 
magnetization  of the iron oxide nanoparticles was taken from the literature, where it 
was measured to 66 emu/g using a SQUID magnetometer [201]. 
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4.2.7 Viscosity Measurement 
Viscosity of 1, 2 and 3% alginate was measured using a rotating viscometer 
(Brookfield Co. HBTD, Stoughton, MA) at 10, 20 and 50 rpm. 1 mg/ml and 5 mg/ml iron 
oxide nanoparticles were mixed with alginate and viscosity was measured. 
 
4.2.8 Micro Computed Tomography Scan 
A 1.5 mm X 1.5 mm area of 0.1 mg/ml magnetic nanoparticles was printed within 
a 5 mm X 5 mm X 2 mm 2% w/v alginate construct and imaged using a MicroCT scanner 
(SkyScan 1172). MicroCT allows non-destructive evaluation of the internal structure and 
composition of the sample based on changes in X-ray absorption. Image resolution was 
set at 2.16 µm with a filter of 1 mm aluminum. The rotation angle was 180º with a 
rotation step of 0.1º. 
 
4.2.9 Statistical Analysis 
Samples were statistically compared using Student’s t-test. Statistical significance 
was established at either p<0.05 (#) or p<0.01 (*). Two-way ANOVA was used to 
compare changes over time, with statistical significance established at p<0.0001. 
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4.3 Results 
4.3.1 Viability of cells printed with magnetic nanoparticles in the alginate 
Bioprinting magnetic nanoparticles along with cells in a biopolymer scaffold may 
provide an effective means to track and manipulate bioactive factors in tissue engineered 
structures. In this set of data printed caption in the figures represent cells printed with 
250µm nozzle tip. We now show that while nanoparticles themselves slightly decreased 
endothelial cell viability, bioprinting had no significant effect (Figure 26A). At 0 and 12 
hours after printing, cell viability did not change significantly for unprinted or printed 
cells with 0 or 0.1 mg/ml nanoparticles in a 1% w/v alginate solution. However, at 36 
hours after printing, PAEC with 0.1 or 1.0 mg/ml nanoparticles were 16% or 35% less 
viable than cells without nanoparticles, respectively. The viability loss was independent 
of the printing process. Cell viability continued to decrease with time up to 60 hours after 
cell printing (ANOVA, p<0.0001). In a long term assay (Figure 26B), endothelial cell 
viability similarly decreased nearly 22% with 1.0 mg/ml iron oxide nanoparticles in the 
alginate 72 hours after printing compared to samples without nanoparticles (ANOVA, 
p<0.0001). No further cell viability decrease was observed from 72 hours to 144 hours, 
showing that cells maintained their viability following the initial nanoparticle toxicity 
effect. 
Increased nanoparticle concentration decreased cell viability, but no additional 
decrease was observed with printing (Figure 26A). PAEC encapsulated in alginate with 
1.0 mg/ml nanoparticles showed 20% lower viability than cells with 0.1 mg/ml 
nanoparticles and 36% lower than the control, suggesting a nanoparticle concentration 
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dependent effect on cell viability. This decreased viability was observed 36 and 60 hours 
after printing, but the printing process itself did not affect cell viability. To confirm that 
the Alamar blue measured cell viability, not a change in cell metabolism, a Live/Dead 
assay was performed on printed samples. The Live/Dead data agreed well with the 
Alamar blue results.  
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Figure 26. Endothelial cell viability decreased in a dose-dependent manner with magnetic 
nanoparticles in the alginate, but printing had no effect. (A) Cell viability for cells printed 
with 0, 0.1, and 1.0 mg/ml nanoparticles in 1% w/v alginate solution, assessed by Alamar 
blue fluorescence over time. (B) Long term cell viability for cells printed with 0 and 1.0 
mg/ml nanoparticles in 1% w/v alginate solution, assessed by Alamar blue fluorescence 
up to 6 days after printing. (n = 3, # p < 0.05, * p<0.01 relative to no nanoparticle 
sample).Cells were printed with 250µm nozzle tip. 
115 
 
 
4.3.2 Effect of Alginate Concentration on Printed Cell Viability 
We next investigated whether alginate concentration, which effectively alters 
biopolymer viscosity, affected printed cell viability. In this set of data printed caption in 
the figures represent cells printed with 250µm nozzle tip. Immediately following printing, 
there was a 20% viability decrease for cells printed with nanoparticles in 2% w/v alginate 
as compared to the 1% w/v alginate (Figure 27). 12 hours after printing, lower viability 
was also observed for control cells with nanoparticles in the 2% w/v alginate. This 
decreased cell viability for cells with nanoparticles in the 2% w/v alginate solution was 
no longer observed at later time points, primarily because cell viability decreased in the 
samples with nanoparticles in 0.5% or 1% alginate. Interestingly, in cell samples without 
nanoparticles, cell viability decreased for both control and printed cells without 
nanoparticles in the 2% w/v alginate solution at 36 and 60 hours (Figure 27C, D). 
Overall, cells without nanoparticles in the 0.5% and 1% w/v alginate solutions 
demonstrated an increase in Alamar blue fluorescence over time, which could represent 
increased cell number or increased cell metabolism. No cell samples in alginate with 
nanoparticles, and no cell samples in 2% alginate, showed this increase in viability with 
time. This effect also was independent of printing. 
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Figure 27. A higher viscosity alginate scaffold decreases cell viability, however effect 
timing depends on printing and nanoparticles. Cell viability for PAEC in 0.5, 1 and 2% 
w/v alginate and 0 or 0.1 mg/ml nanoparticles at 0 (A), 12 (B), 36 (C) and 60 (D) hours 
after printing.    (n = 3, # p < 0.05, relative to 1% w/v alginate sample).Cells were printed 
with 250µm nozzle tip. 
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4.3.3 Effect of Cellular Nanoparticle Uptake on Printed Cell Viability 
Magnetically labeled cells, internally loaded with iron oxide nanoparticles, could 
be used to track and move cells printed within a tissue engineered structure. The viability 
of nanoparticle loaded cells was examined after printing in 1% alginate and an initial 
dispensing pressure of 5 psi.  Both control and printed samples without nanoparticles 
showed increased viability at timepoints up to 60 hours. However, a steep decrease in cell 
viability was observed from 0 to 36 hours for both control and printed cells loaded with 
either 0.1 or 1.0 mg/ml nanoparticles (Figure 28A). Printed cells showed the most 
dramatic change, with a 40% decrease in the Alamar blue fluorescence when compared to 
printed cells without nanoparticles at 36 hours. This viability change was in direct 
contrast to the lack of printing effect for samples with nanoparticles in the alginate. While 
early cell viability was significantly decreased, there was no significant change at 
timepoints after 36 hours, suggesting stabilization of the remaining cell population. When 
printing pressure was decreased to 2 psi, cell viability increased almost 20% (Figure 
28B).  
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Figure 28. Cell viability decreased for cells loaded with 0.1 and 1.0 mg/ml nanoparticles 
and the decrease was accentuated by printing.  PAEC viability for cells printed in 1% 
alginate at a dispensing pressure of (A) 5psi and (B) 2 psi. (n = 3, # p < 0.05, * p<0.01 
relative to no nanoparticle sample). Cells were printed with 250µm nozzle tip. 
 
 
 
 
4.3.4 Effect of Nozzle Size and Printing Pressure on Cell Viability 
Biofabrication conditions might significantly affect the nano-bioprinting system 
efficacy. We now show that while nanoparticles in the alginate slightly decreased 
endothelial cell viability, nozzle size had no significant effect (Figure 29A). At 0 and 12 
hours after printing, cell viability did not change significantly for printed cells with 0, 0.1 
and 1.0 mg/ml nanoparticles in a 1% alginate solution. However, 36 hours after printing, 
PAEC with 0.1 or 1.0 mg/ml nanoparticles were 16% or 35% less viable than cells 
printed without nanoparticles, respectively. The viability loss was independent of nozzle 
size. Cell viability continued to decrease up to 60 hours after cell printing (ANOVA, 
p<0.0001), however long term experiments showed no further cell viability decrease after 
60 hours (data not shown).  
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Changes in the nozzle tip size might affect magnetically labeled cell viability 
during printing process. So nanoparticle loaded cell viability of cells printed with 250 and 
410 µm nozzle tips was examined after printing. While viability was unchanged for 
printed cells without nanoparticles, viability decreased from 0 to 36 hours for printed 
cells loaded with either 0.1 or 1.0 mg/ml nanoparticles (Figure 29B). However, nozzle 
size did not affect cell viability. Nanoparticle loaded cells printed with either a 250 and 
410 µm diameter nozzle demonstrated 36% viability loss compared to cells printed 
without nanoparticles at 36 hours. While early cell viability was decreased, there was no 
significant change after 36 hours, suggesting stabilization of the remaining cell 
population.  
Increasing printing pressure from 5 psi to 40 psi decreased cell viability by 25% 
when nanoparticles were in the alginate (Figure 29C), and 26% for magnetically labeled 
cells (Figure 29D)  immediately following bioprinting. Cell viability continued to 
decrease in a similar manner for both nanoparticle conditions and printing pressures. The 
combined effect of printing pressure and nanoparticles affected cell viability in an 
additive manner and at different times, suggesting no interaction between the two 
printing parameters. 
 
120 
 
 
 
Figure 29. Bioprinted endothelial cell viability decreased with nanoparticles and printing 
pressure, but nozzle diameter has no effect. Cell viability after bioprinting with 250 µm 
and 410 µm diameter nozzles, 1% alginate with 0, 0.1, and 1.0 mg/ml magnetic 
nanoparticles either (A) in the alginate or (B) loaded inside cells. Cell viability after 
bioprinting with 250µm diameter nozzle, 1% alginate at 5 and 40 psi printing pressure 
with 1.0 mg/ml nanoparticles either (C) in the alginate or (D) inside cells. (n = 3, # p < 
0.05, * p<0.01 relative to 0 mg/ml nanoparticle sample). 
 
 
 
 
4.3.5 Nanoparticle and Cell Manipulation inside the Alginate 
Nanoparticles were magnetically manipulated within the alginate to determine if 
nanoparticles could be used to move bioactive factors after printing. 1.0 mg/ml 
nanoparticles were homogenously distributed in 1%, 2%, and 3% w/v alginate, printed in 
bulk samples, and left as a viscous liquid or crosslinked with calcium chloride to form a 
gel (Figure 30A, C, E; Figure 30G, I, K). Nanoparticles printed in either 1% or 2% w/v 
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alginate without calcium chloride moved towards the NdFeB magnet placed under the 
cell culture dish within a minute (Figure 30B, D; arrows indicate nanoparticles at the 
magnet edge). However, no nanoparticle movement was observed in the 3% w/v alginate 
solution, likely due to the high alginate solution viscosity (Figure 30F). When the 
samples were crosslinked with calcium chloride, nanoparticles similarly moved toward 
the magnet edge in the 1% and 2% w/v alginate, but not 3% alginate. (Figure 30H, J, L). 
However, the nanoparticles moved more slowly, and less spatial repositioning of 
nanoparticles was observed.  
We next investigated if cells loaded with magnetic nanoparticles could be moved 
within the alginate biopolymer. PAEC magnetically labeled with nanoparticles were 
initially homogenously distributed in 0.5% and 1% w/v alginate (Figure 31A, E, I; higher 
magnification in Figure 31B, F, J). Magnetically labeled cells moved toward the NdFeB 
magnet placed under the cell culture dish (Figure 31C, G, K). At higher magnification, 
individual cells were seen at the magnet edge (arrows in Figure 31D, H and L). Isolated 
nanoparticles can also be seen in the alginate, which are likely artifacts of incomplete 
nanoparticle removal from the cell solution when it was mixed with alginate. 
Magnetically labeled cells continued to cluster at the magnet edge in the cross-linked 
alginate, but no movement was observed in alginate concentrations higher than 1%.  
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Figure 30. Bioprinted nanoparticles in the alginate scaffold move towards the magnet in a 
manner dependent on scaffold viscosity. 1.0 mg/ml nanoparticles homogenously 
distributed in 1%, 2% and 3% w/v alginate (A, C, E) moved towards the NdFeB magnet 
for the 1% and 2%, but not 3%, alginate (B, D, F). When samples were crosslinked in 
CaCl2 (G, I, K), nanoparticles moved more slowly and less nanoparticle movement was 
observed (H, J, L). Dash lines indicate magnet location. Scale bar is 1 mm.  
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Figure 31. Magnetically labeled cells can be moved within the alginate scaffold using a 
magnet. PAEC loaded with 1 mg/ml nanoparticles homogenously distributed in 0.5 and 
1% w/v alginate (A, E; higher magnification B, F) and in 0.5% alginate crosslinked with 
CaCl2 (I higher magnification J). Cells moved toward an NdFeB magnet placed under the 
culture dish (C, G, I; higher magnification D, H, L).Dashed lines indicate magnet 
location. Arrows indicate magnetically labeled cells accumulated at the magnet edge. 
 
 
 
 
Specified patterns of nanoparticles and magnetically labeled cells were printed 
and moved using a magnetic field. 1% alginate with iron oxide nanoparticles was printed 
in a pattern (Figure 32A), and a magnetic field was used to move the nanoparticles to the 
printed pattern tips (Figure 32B). Basic shapes (lines and rectangles) of either 
nanoparticles (Figure 32C, D; Figure 32G, H) or magnetically labeled cells (Figure 32E, 
F) were moved to new locations while maintaining the original pattern. 
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Figure 32. Printed shapes of nanoparticles or magnetically labeled cells in alginate were 
moved to new locations using a magnetic field. (A, B) 1% alginate with nanoparticles 
was printed in a specified pattern. Nanoparticles were moved to the pattern tips using a 
magnetic field. (C, D) Nanoparticles or (E, F) magnetically labeled cells were printed in a 
600 µm thick line in a 25x25 mm 2% alginate square. The printed line pattern was moved 
using a magnetic field. Arrow shows the magnet location. (G, H) Nanoparticles printed in 
a rectangle were moved towards the magnet while maintaining the rectangular pattern. 
 
 
 
 
4.3.6 Effect of Nanoparticles on Alginate Viscosity 
Biopolymer scaffold viscosity affects printing resolution, therefore alginate 
viscosity at different concentrations and with nanoparticles was measured. Alginate 
viscosity increased with alginate percentage and decreased with rotational velocity. At 20 
rpm, viscosity increased from 400 cP for 1% alginate to 1250 cP for 2% alginate and 
8000 cP for 3% alginate (Figure 33A-C). Alginate viscosity decreased more than 25% 
with increasing velocity (strain rate) for all concentrations, with 3% alginate showing the 
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most dramatic non-Newtonian properties. 1.0mg/ml and 5.0 mg/ml iron oxide 
nanoparticles did not significantly affect 1% alginate viscosity, at least within the 
measurement capability of the system (Figure 33A). However, in 2% (Figure 33B) and 
3% (Figure 33C) alginate, 5.0 mg/ml nanoparticles resulted in a statistically significant 
increase in alginate viscosity (p<0.05).  
 
 
 
 
 
Figure 33. Alginate viscosity decreased with velocity, but only high nanoparticle 
concentrations increased viscosity. Viscosity with 0, 1.0, and 5.0 mg/ml nanoparticles 
added for (A) 1% alginate, (B) 2% alginate, and (C) 3% alginate. (n=3, # p< 0.05). 
 
 
 
4.3.7  Effect of Alginate Viscosity and Nanoparticle Cluster Size on Nanoparticle 
Velocity  
Nanoparticle velocity in the alginate biopolymer was quantified as a function of 
alginate viscosity and nanoparticle cluster size. Nanoparticle velocity was four times 
faster in 1% alginate than 2% alginate (Figure 34A). Due to limited testing length, the 
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nanoparticles did not reach a constant velocity. Instead, they accelerated at 0.385 mm/s2 
in 1% alginate, and much slower at 0.088 mm/s2 in 2% alginate. While ideally 
nanoparticles would be monodispersed in the alginate biopolymer, particles aggregated in 
clusters, particularly when a magnetic field was applied. Velocities for three nanoparticle 
cluster sizes were compared in 2% alginate. The larger cluster sizes moved faster in the 
alginate, which agreed with the theoretical calculation that nanoparticle velocity increases 
with the square of particle diameter. In our experiments, 200 µm sized clusters moved 
five times faster than 50 µm sized cluster when the nanoparticles were 0.9 mm from the 
magnet (Figure 34B). Experimentally determined nanoparticle cluster velocities showed 
good agreement with calculated velocities (Table 3).  
 
 
Figure 34. Nanoparticle velocity increased at low alginate concentrations and for larger 
nanoparticle clusters (A) Nanoparticle velocity in 1% and 2% alginate biopolymer, and 
(B) Nanoparticle velocity as a function of agglomerated nanoparticle cluster size.  
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Table 3. Comparison of measured nanoparticle velocity with calculated velocity. 
@ 0.9 mm 50 µm 100 µm 200 µm 
Measured (mm/s) 0.39 1.46 2.57 
Calculated (mm/s) 0.27 1.71 4.00 
 
 
 
 
4.3.8 Effect of Nanoparticles on Printing Resolution  
Nanoparticles may alter biopolymer flow rate, and therefore affect bioprinting 
resolution. Lines were printed with and without nanoparticles with 250 µm and 410 µm 
nozzles at 2, 3.5, and 5 psi printing pressure (Figure 35A). Printed lines were the same 
width as the nozzle diameter at the low 2 psi pressure. As printing pressure increased to 
3.5 and 5 psi, printed line width increased linearly to more than twice the nozzle diameter 
(Figure 35B). However, the presence of nanoparticles in alginate did not change printed 
line width (Figure 35C). Printing resolution was maintained with nanoparticles, as shown 
by the complex patterns printed with (Figure 36B, D, F) and without (Figure 36A, C, E) 
nanoparticles. 
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Figure 35.  Printing pressure increased line width, but nanoparticles did not affect 
printing resolution. (A) Lines printed with and without nanoparticles using 250 and 410 
µm nozzles and 2, 3.5, and 5 psi printing pressures. (B) Measured line width as a function 
of nozzle size and printing pressure. (C) Measured line width as a function of printing 
pressure, with and without nanoparticles, for the 410 µm nozzle. 
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Figure 36. Printing resolution for complex patterns was maintained with nanoparticles in 
the alginate. Shapes printed with alginate (A, C, E) and alginate with nanoparticles (B, D, 
F) were imaged using a CCD camera. 
 
 
 
 
4.3.9 MicroCT Scan of 3D Deposited Tissue Scaffold 
Magnetic nanoparticles printed within three-dimensional alginate scaffolds were 
imaged by MicroCT to determine if nanoparticle printing would allow non-invasive 
tracking of bioactive factors and cell location in tissue engineering structures. A 
nanoparticle-alginate prepolymer solution was encapsulated in alginate biopolymer 
solution using layer-by-layer deposition with the solid freeform fabrication based direct 
cell writing system. Printed nanoparticle clusters are clearly visible by MicroCT scan of 
the three-dimensional tissue scaffold (arrows, Figure 37).  
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Figure 37. Nanoparticles printed within a three-dimensional alginate biopolymer are 
visible by MicroCT. Images represent sample cross sections in the (A) translational 
plane, (B) coronal plane and (C) sagittal plane. The red and blue lines on the translational 
plane (A) show the sagittal and coronal plane cuts, respectively (B, C). The green line in 
the sagittal and coronal plane views represents the translational plane cut. Arrows 
indicate nanoparticles. Scale bar is 500 µm. 
 
 
 
 
4.4 Discussion 
Enhanced non-destructive imaging of cellular and biochemical interactions within 
three-dimensional tissues would advance knowledge of tissue development, and the 
ability to precisely pattern cells and bioactive factors throughout the tissue growth 
process would improve fabrication of complex tissues. A combination of bioprinting, 
which allows initial patterning, and superparamagnetic nanoparticles, which allow 
tracking and re-patterning, could help realize these tissue engineering goals. Furthermore 
the effect of biofabrication parameters on bioprinting efficacy is critical for 
implementation of novel cell deposition systems in tissue engineering. We now show that 
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magnetic nanoparticles can be bioprinted for tissue engineering applications. 
Nanoparticles in the biopolymer scaffold or inside cells decrease printed cell viability, 
but that nanoparticles do not accentuate the effects of nozzle size and printing pressure. 
In addition, while printing cells loaded with nanoparticles did decrease cell viability, the 
viable cells were stabilized shortly after printing. Magnetically labeled biofactors and 
cells could be moved within the alginate structures in the presence of an externally 
applied magnetic field, or imaged non-destructively using MicroCT. After printing, 
biopolymer viscosity and nanoparticle cluster size control nanoparticle velocity within 
the scaffold in response to a magnetic field. Since lower nanoparticle concentrations do 
not significantly affect biopolymer viscosity, printing resolution and patterning 
capabilities are maintained for the nano-bioprinting system. These results support 
appropriate biofabrication parameter selection for the hybrid nano-bioprinting system, 
which enables initial patterning followed by non-destructive imaging and re-patterning of 
cells and bioactive factors in tissue engineered constructs.  
 Sodium alginate was used in all experiments because it is non-toxic, remains a 
viscous liquid at room temperature, and cross-links to form a gel under mild conditions. 
However, endothelial cells are unable to specifically interact with alginate, which 
prevents cell anchorage and attachment in the biopolymer [202]. The cells have a 
rounded morphology because they are encapsulated in, not adhered to, the polymer 
scaffold. Since the printing system operates at room temperature, we are currently unable 
to print polymers such as collagen, to which the cells would attach, because collagen 
solidifies into a stiff gel at room temperature. In our experiments, alginate is 
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advantageous because it maintains cell number without proliferation, which allows 
improved observation of cell death. As a future work of this study, we suggest to 
incorporate a cooling system into our bioprinting device to print collagen gels. It will 
then make it possible to study cell viability and proliferation after cells printed with 
nanoparticles have attached to the scaffold. 
By bioprinting nanoparticles in the biopolymer, bioactive factors such as growth 
factors, antibodies, drugs, and genes conjugated to the magnetic nanoparticles can be 
precisely patterned within a three-dimensional scaffold. Chemical coupling via amide or 
ester bonds has been used by others to conjugate bioactive factors to iron oxide 
nanoparticles. Linker molecules, including 1-ethyl-3-(3-dimethylaminopropyl) carbodi-
imide hydrochloride (EDCI), N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP), or 
N-hydroxysuccinimide were used to attach targeting ligands and proteins to nanoparticle 
surfaces [4]. Insulin, lactoferrin and ceruloplasmin were successfully conjugated to 
superparamagnetic iron oxide nanoparticles using EDCI. These nanoparticles were then 
targeted to cell surface receptors, thereby avoiding endocytosis, to achieve tissue and 
cell-specific drug targeting [67, 68]. Magnetic nanoparticles have also been dually 
conjugated, both with a ligand specific for a target cancer cell receptor and a cancer 
therapy drug. For instance, a radiolabeled anti-vascular endothelial growth factor (VEGF) 
monoclonal antibody was conjugated to magnetic nanoparticles to both target and deliver 
radiation therapy to liver cancer [203]. By chemically conjugating bioactive factors to the 
nanoparticles, it would be possible to initially pattern the bioactive factors in the scaffold 
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and then move them during tissue growth. This technique could, for example, provide 
endothelial cells with a changing growth factor gradient to promote angiogenesis.  
In the current study, we observed decreased viability for cells exposed to both low 
and high nanoparticle concentrations in the alginate, independent of bioprinting. 
However, in our previous studies, endothelial cells viability was largely preserved in two-
dimensional culture up to an iron oxide nanoparticle concentration of 0.5 mg/ml [181]. 
This apparent contradiction might be related to differences in two- and three-dimensional 
endothelial cell culture. In two-dimensional cultures, endothelial cells form a stable, 
confluent monolayer, whereas these same  cells form tubes when grown in a three-
dimensional matrix [204]. The three-dimensional angiogenic endothelial cell phenotype 
may be more susceptible to nanoparticle toxicity than the two-dimensional monolayer. 
Cells may be able to uptake more nanoparticles in the three-dimensional alginate 
structure since they are exposed to nanoparticles on all sides. In two-dimensional culture, 
cells interact with nanoparticles only at their apical surface. The effect could also be 
specific to the alginate scaffold since cells do not attach to the alginate. These 
attachment-dependent cells may experience changes in critical cell functions when 
encapsulated, which coupled with functional changes caused by nanoparticle uptake, may 
enhance nanoparticle cell toxicity [205]. Interestingly, long term tests showed that cell 
viability is stable after 72 hours, perhaps because all available nanoparticles in the 
vicinity of a cell have already been taken up.  
The printing process itself did not impact endothelial cell viability when 
nanoparticles were mixed with the alginate. We hypothesize that cell viability is 
134 
 
 
preserved because nanoparticles are free to move within the alginate without damaging 
cells during printing. In direct contrast, when nanoparticles were loaded inside cells, there 
were fewer viable printed cells than control cells but this decrease in viability was found 
to be related to the printing pressure. The system operates at printing pressures ranging 
from 1 - 40 psi. The majority of our experiments were conducted at a printing pressure of 
5 psi, which was shown in previous studies to maintain cell viability. Only at pressures 
greater than 20 psi did cell viability decrease [110]. As dispensing pressure was lowered 
to 2 psi, the forces imposed on the cell as it moved through the nozzle decreased, which 
likely increased cell viability. However the printing process at 2 psi dispensing pressure 
took more than twice as long, so for automated mass production, higher printing 
pressures such as 5 psi might still be preferred with the known loss in cell viability. At 
both pressures, cells without magnetic nanoparticles recovered in time from the 
mechanical perturbation and eventually reached a steady state condition.  
When cells uptake nanoparticles, they form vacuoles which disrupt the cell 
cytoskeleton [68]. Cells with a disrupted cytoskeleton may experience increased damage 
due to printing-induced forces. Alternatively, the nanoparticles inside cells may be more 
likely to damage the cell membrane through direct shear effects during the printing 
process. As the cells are pushed through the nozzle, the nanoparticles may break through 
the cell membrane or the nucleus, causing irreversible damage. It is also possible that 
cells loaded with nanoparticles are already in a state of internal stress, perhaps due to 
reactive oxygen species (ROS). Intracellular ROS generation is hypothesized to increase 
with nanoparticle uptake, leading to protein, DNA and tissue injury and eventual cell 
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death [113]. The addition of mechanical stress from the bioprinting process may be more 
toxic when cells are already biochemically stressed by the internalized nanoparticles prior 
to the printing process. Both printing parameters and nanoparticle conditions will need to 
be optimized to minimize cell death.  
Nozzle size did not affect cell viability, whether cells were printed with 
nanoparticles in the alginate or inside the cells. These results agree with previous research 
suggesting that only the smallest nozzle size (150 µm) decreased cell viability after 
printing. We had previously hypothesized that nanoparticles might effectively decrease 
nozzle size during printing, since the nanoparticles are more rigid than alginate or cells. 
However, cell viability appears to be preserved because nanoparticles are free to move 
within the alginate or cells without damaging the cell membrane during printing. We had 
also postulated that nanoparticles in cells, which increase intracellular reactive oxygen 
species and put cells in a stressed state [68], might sensitize cells to increased shear stress 
experienced with smaller nozzle sizes. Since no effect was observed, nozzle size does not 
appear to be significant at larger nozzle sizes. However, there might be a nanoparticle-
induced cell viability loss at smaller nozzle sizes. 
In contrast to nozzle size, higher dispensing pressures decreased cell viability for 
cells printed with and without nanoparticles. Cell viability decreased immediately after 
printing due to the higher pressure of 40 psi and then continued to decline due to 
nanoparticle effects. The early viability loss was effectively the same for cells printed 
with and without nanoparticles, suggesting that the printing pressure effect was not 
accentuated by nanoparticles. These results are comparable to previous studies, in which 
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printing pressure similarly affected a hepatocyte cell line (HepG2) viability [110]. The 
hepatocytes recovered to the original viability level by 24 hours after printing, suggesting 
that cell metabolic activity was only temporarily compromised by higher printing 
pressures. We did not observe this recovery effect, perhaps because primary endothelial 
cells were used rather than a hepatic carcinoma cell line. 
Cell toxicity could alternatively be decreased, while still allowing cell tracking, 
by attaching bioconjugated nanoparticles to the cell membrane. However it might be 
difficult to manipulate cells with externally-attached nanoparticles. The nanoparticles 
may detach during printing due to mechanical forces as the cell moves through the 
nozzle, or the nanoparticles may detach during cell movement through the scaffold due to 
viscous drag. Furthermore, attaching nanoparticles to cells via a surface receptor could 
activate unwanted intracellular signaling, or prevent the cell from using that receptor to 
perform a particular function. While keeping these challenges in mind, as a future work, 
we suggest investigating whether printing and moving cells with membrane-attached 
nanoparticles is feasible and maintains cell viability. 
Our studies revealed that cell viability decreased for samples printed in 2% w/v 
alginate as compared to 1.0% w/v alginate with and without any nanoparticles. The high 
solution viscosity may have exposed cells to higher printing forces during the cell 
dispensing process. Cell membranes are highly fragile to mechanical loads, and excessive 
membrane perturbation can lead to cell death [206]. The initial cell viability change 
observed from 0 to 12 hours in samples with nanoparticles in 2% alginate suggests that 
nanoparticles further increased the biopolymer viscosity. At later times (36 and 60 hours 
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after printing), the presence of nanoparticles inside the alginate overcame this initial 2% 
alginate cell viability decrease, and there was no difference among the different alginate 
samples. Even the cells without nanoparticles demonstrated decreased viability in the 
long term due to the 2% alginate, which was in contrast to the recovery process for cells 
in 1% alginate. This suggests that endothelial cell health is compromised in the stiffer gel, 
however additional studies are needed for confirmation. 
While cells in our experiments showed lower viability in stiffer gels, other studies 
have shown that cells prefer stiffer substrates. In two-dimensional culture, cells form 
large, stable focal adhesions on stiff substrates, whereas cells form irregularly shaped, 
dynamic adhesions on softer substrates [207]. However for three-dimensional cell 
studies, cell migration speed and viabiltiy may depend not only on the substrate stiffness 
but also substrate adhesivity or cell–matrix adhesion availability [208]. Peyton and 
Putnam [209] found that when cell adhesiveness was reduced using an integrin-blocking 
antibody, the maximum cell migration speed shifted from stiffer to softer Matrigel 
substrates. Our printed cells are in three-dimensional alginate gels to which they do not 
attach, therefore it is possible that unattached cells are more viable in softer alginate gels. 
There are rich opportunities for future studies to address mechanisms underlying these 
distinct differences in cell viability and migration in two- and three-dimensional 
environments and the relationship between substrate stiffness and cell-matrix adhesion.  
 The hybrid nano-bioprinting system allows initial nanoparticle and cell patterning 
by computer-controlled printing, after which nanoparticles and cells can be moved to a 
new location either in the initial pattern or in a new pattern defined by the magnetic field. 
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We now also show that nanoparticle movement depends on alginate viscosity. 
Nanoparticles moved towards the NdFeB magnet in 1% and 2%, but not 3% alginate. As 
seen from equation (4), the nanoparticle velocity inside the alginate is inversely 
proportional to the medium viscosity and directly proportional to the magnetic field 
gradient. So in a higher viscosity biopolymer, a stronger magnetic field will be needed to 
move the same nanoparticle. Even though nanoparticles did not noticeably move in 3% 
w/v alginate, and nanoparticle movement decreased with crosslinking, it may be possible 
to move these nanoparticles in the more viscous biopolymer with a stronger magnet. 
These nanoparticles could even be removed prior to tissue implantation, which would 
decrease any potential negative effects in vivo. When a magnet was placed next to a 
nanoparticle-alginate scaffold, nanoparticles moved completely out of the alginate and 
attached to the magnet.  
Alginate exhibits non-Newtonian shear-thinning behavior, meaning that solution 
viscosity decreases with increasing shear rate [210]. Alginate viscosity depends on 
alginate concentration and the number of monomers in alginate chains (molecule length) 
[211]. In general, liquid viscosity increases upon the addition of rigid spherical or non-
spherical particles because particles disturb the fluid flow. With greater particle 
clustering, or more open cluster structure, a larger change in liquid viscosity is observed 
[212].  In our experiments, nanoparticles only increased alginate viscosity for high 
alginate concentrations and very high nanoparticle concentrations. At these high 
concentrations, nanoparticles likely form large clusters and impact liquid rheology. This 
viscosity increase could amplify the mechanical forces experienced by cells during 
139 
 
 
printing and thus impact cell viability, but it would enhance printing resolution [194]. 
Since our printed nanoparticle concentrations were 1.0 mg/ml and lower, alginate 
viscosity is not significantly affected within our system.  
Experimental magnetic nanoparticle movement depended on particle size and 
shape, suspending fluid characteristics, and the external magnetic field strength, which 
agreed well with theoretical calculations [199]. Discrepancies between experiment and 
theory could be related to the testing field length, nanoparticle clustering, and local 
nanoparticle effects on fluid viscosity. Due to limitations in the experimental setup size, 
nanoparticles did not reach a terminal velocity but continued to accelerate as they 
approached the magnet. Since the velocity was calculated for nanoparticles with no net 
applied force, and therefore no acceleration, the experimental conditions did not exactly 
match the theoretical case. The mathematical model also assumed nanoparticles were 
single spheres.  However, under the effect of magnetic field, nanoparticles aligned, 
rotated and formed linear chain-like aggregates. The diverse nanoparticle shapes and 
sizes affected similarity between experiment and theory.  Finally, high nanoparticle 
concentrations and clustering in response to the magnetic field may have changed the 
local fluid viscosity [213].  Large nanoparticle clusters might even have prevented the 
movement of smaller nanoparticles by disturbing the flow stream, further deviating 
experimental from calculated velocities. While inconsistencies existed between the 
experimental conditions and the model assumptions, the measured and calculated 
velocities were adequately close to justify using this model to determine nanoparticle 
movement in a tissue engineering scaffold in response to a magnetic field.  
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The inclusion of nanoparticles in the alginate biopolymer did not reduce printing 
resolution. For alginate with and without nanoparticles, line width increased with nozzle 
diameter and printing pressure in accordance with the literature [189-191, 194]. Existing 
biofabrication procedures could be used to regulate the size, shape, porosity, and 
mechanical properties of a tissue engineering construct created with the nano-bioprinting 
system. The slight increase in biopolymer viscosity with nanoparticles would enhance 
printing resolution, but might also slightly increase the scaffold elastic modulus. This 
effect would require further investigation, if high nanoparticle concentrations are used. 
Magnetically labeling cells allows non-destructive imaging by MicroCT in the 3D 
tissue engineering scaffold.  The intracellular nanoparticle loading should be optimized to 
obtain maximum signal intensity while at the same time protecting cell viability. Our 
studies showed that it may be possible to qualitatively determine the nanoparticle or 
magnetically labeled cell density at a given location by MicroCT signal intensity. A 6 
fold increase in signal intensity was observed for 100,000 cells loaded with 1.0 mg/ml 
iron oxide nanoparticles as compared to the same cell number loaded with 0.1 mg/ml 
nanoparticles. However, excess nanoparticles that were not taken up by cells could also 
increase the MicroCT signal intensity. Nanoparticle loading parameters should be 
selected to minimize free nanoparticles, and any excess nanoparticles should be 
thoroughly washed away prior to cell printing. Magnetically labeled dead cells will light 
up on the MicroCT scans, which may decrease live cell tracking efficacy. An additional 
assay, such as Alamar blue or Live/Dead, may be needed to differentiate live from dead 
cells. Live magnetically labeled cells would also respond to biochemical signals by 
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proliferating, moving, and forming three-dimensional structures, which should help 
distinguish them from dead cells in MicroCT images.  
While cell viability was decreased with nanoparticle loading and printing, there is 
still potential by optimizing nanoparticle concentration and printing parameters to 
bioprint magnetically labeled cells. In tissue engineering, the development of complex 
three-dimensional tissues requires various cell types, such as smooth muscle and 
endothelial cells for vascular systems or hepatocytes and sinusoidal endothelial cells for 
liver. However cell-cell interactions are difficult to manipulate in coculture systems, even 
in two-dimensional cultures. Ito et al. [111] used magnetic force to place magnetically 
labeled cells onto target cells and promote heterotypic cell-cell adhesion. The solid 
freeform cell writing system could enable assembly of three-dimensional patterned tissue 
engineering constructs with various magnetically labeled cell types. Through MicroCT, 
both bioactive factors and cells could be non-invasively imaged within the tissue 
engineering scaffold, which would allow longitudinal studies of tissue development. This 
hybrid nano-bioprinting technique, which uses a combination of bioprinting and active 
magnetic patterning, could dramatically impact our ability to understand and re-create 
complex tissue development. 
All of our experiments used a relatively low cell concentration in the alginate 
polymer. Higher cell density may be required to achieve critical cell mass for tissue 
engineering applications. Based on the studied parameters, including nanoparticle 
concentration, alginate viscosity, and nanoparticle movement within the alginate, we do 
not anticipate significant changes in printed cell viability or bioprinting quality with 
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higher printed cell concentrations. Neither increasing nanoparticle concentration nor 
decreasing nozzle diameter diminished cell viability. This suggests that more cells could 
be incorporated in the alginate without causing cell damage through cell-cell or cell-
nozzle interaction during printing. A higher cell concentration may increase alginate 
viscosity, which in turn may impact cell viability. However, increasing nanoparticle 
concentration in the alginate had only a minor effect on alginate viscosity; therefore we 
do not anticipate a large change in alginate viscosity with increased cell density. Higher 
cell concentration may also decrease cell movement in the alginate in response to a 
magnetic field, since larger nanoparticle clusters moved more slowly. However, with 
time and large magnetic forces, cell movement should still be possible. Finally, since 
bioprinting resolution was unchanged with nanoparticles in the alginate, we similarly 
expect that resolution will be maintained with higher cell concentrations. 
We have shown that a solid freeform fabrication system can be used to create 
magnetically functionalized three-dimensional tissue scaffolds, which can be manipulated 
after printing using a magnetic field. This new hybrid nano-bioprinting system enables 
enhanced tissue engineering capabilities, including imaging and repositioning cells and 
bioactive factors after initial deposition. Our data indicate that nanoparticle inclusion 
within a solid freeform fabrication system is unlikely to significantly change 
biofabrication parameters unless extremely high nanoparticle concentrations are used. A 
theoretical model for superparamagnetic nanoparticle movement in response to a 
magnetic field can be used to approximate nanoparticle repositioning within the scaffold. 
As a future work, we suggest to improve printed magnetically labeled cell viability by 
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exploring different nanoparticle sizes and shapes, as well as attaching nanoparticles to the 
cell membrane. Nanoparticles might be conjugated with bioactive factors, and cells might 
be printed in collagen gels with a cooled printing system. Finally, complex magnet 
arrangements might be used to control cell movement and patterning after printing in the 
tissue engineered construct. 
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CHAPTER V: CONCLUSIONS AND FUTURE WORK 
 
 
5.1 Summary of Principle Findings  
Superparamagnetic iron oxide nanoparticles are used in diverse applications, 
including optical magnetic recording, catalysts, gas sensors, targeted drug delivery, 
magnetic resonance imaging and hyperthermic malignant cell therapy. Nanoparticle 
combustion synthesis has significant advantages, including improved nanoparticle 
property control and commercial production rate capability with minimal post-
processing. In the current work, superparamagnetic iron oxide nanoparticles were 
produced by flame synthesis using a coflow flame. Final iron oxide nanoparticle 
morphology, elemental composition, and particle size was controlled by changing flame 
configuration (diffusion and inverse diffusion), flame temperature, and additive loading. 
The synthesized nanoparticles were primarily composed of two well known forms 
of iron oxide, namely hematite αFe2O3 and magnetite Fe3O4. We found that the 
synthesized nanoparticles were smaller for an inverse diffusion flame as compared to a 
diffusion flame configuration when CH4, O2, Ar and N2 gas flow rates were kept 
constant. To investigate the effect of flame temperature, CH4, O2, Ar gas flow rates were 
kept constant, and N2 gas was added as a coolant to the system. TEM analysis of iron 
oxide nanoparticles synthesized using an inverse diffusion flame configuration with N2 
cooling demonstrated that particles no larger than 50-60 nm in diameter can be grown, 
indicating that nanoparticles did not coalescence in the cooler flame. Raman spectroscopy 
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showed that these nanoparticles were primarily magnetite, as opposed to the primarily 
hematite nanoparticles produced in the hot flame configuration. To understand the effect 
of additive loading on iron oxide nanoparticle morphology, an Ar stream carrying 
titanium-tetra-isopropoxide (TTIP) was flowed through the outer annulus along with the 
CH4 in the inverse diffusion flame configuration. When particles were synthesized in the 
presence of the TTIP additive, larger monodispersed individual particles were 
synthesized as observed by TEM. So with this study we show that iron oxide 
nanoparticles of varied morphology, composition, and size can be synthesized and 
controlled using flame synthesis method by varying flame configuration, flame 
temperature, and additive loading.    
Then we compared flame synthesized iron oxide nanoparticle interaction with 
endothelial cells to commercially available iron oxide nanoparticles. We selected a 
heterogeneous mixture of 6-12 nm diameter hematite and magnetite nanoparticles with 
superparamagnetic properties, which were produced by an inverse diffusion flame 
configuration with N2 cooling. Endothelial cell transmission electron microscopy and 
scanning electron microscopy, confirmed by energy dispersive spectroscopy, 
demonstrated that flame synthesized nanoparticles were ingested into cells in a similar 
manner to commercially available nanoparticles. The flame synthesized particles showed 
no statistically significant toxicity difference from commercially available nanoparticles, 
as measured by Live/Dead assay, Alamar blue, and lactase dehydrogenase release. 
Neither type of nanoparticle affected cell proliferation induced by fibroblast growth 
factor-2. These studies suggested that the iron oxide nanoparticles we synthesized by 
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flame synthesis are equally non-toxic to cells as the commercially available ones, and 
therefore are comparable to commercially available nanoparticles for biological 
applications.  
We also showed that when iron oxide nanoparticles were uptaken by PAEC, they 
localized inside the cell cytoplasm as aggregated clusters. Nanoparticle uptake in the cell 
cytoplasm increased ROS formation in cells during the first three hours after uptake. ROS 
formation was found to induce actin cytoskeleton disruption, and actin fibers started to 
elongate after 4 hours. Actin fiber elongation continued for 12 hours after uptake. ROS 
blockers also blocked actin cytoskeleton elongation, which points to a coupled reaction 
between ROS formation and actin cytoskeleton disruption. We demonstrated for the first 
time that iron oxide nanoparticles result in endothelial cell ROS formation in a dose 
dependent manner, and this ROS formation leads to actin cytoskeleton disruption. We 
further showed that we can block the negative effects of the nanoparticles on the cell 
cytoskeleton by blocking the ROS formation.  
After synthesizing iron oxide nanoparticles that were comparable to commercially 
available ones, and studying nanoparticle toxicity, we investigated possible applications 
of iron oxide nanoparticles in tissue engineering. We developed a new hybrid nano-
bioprinting technique that facilitates manipulation and tracking of cells and bioactive 
factors within a three-dimensional tissue construct. This technique combined the initial 
patterning capabilities of syringe-based cell deposition with the active patterning 
capabilities of superparamagnetic nanoparticles. Superparamagnetic iron oxide 
nanoparticles, either in the alginate biopolymer or loaded inside endothelial cells, were 
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bioprinted using a solid freeform fabrication direct cell writing system. Bioprinting did 
not impact cell viability when nanoparticles were in the alginate, however it did have a 
pressure-dependent effect when nanoparticles were inside cells. Nanoparticles did not 
change bioprinting resolution. Nanoparticles in the alginate and loaded in cells were 
moved using an external magnet, and nanoparticle velocity depended on nanoparticle 
diameter and scaffold viscosity. These results agreed with a mathematical model of 
nanoparticle movement. Finally, nanoparticles in the alginate and in cells were imaged by 
MicroCT. The hybrid nano-bioprinting method enabled us to non-invasively manipulate 
and track nanoparticles and cells within tissue engineering structures. 
 
 
5.2 Suggested Future Work 
5.2.1 Nanoparticle Synthesis 
With the recent awareness of nanoparticles and their promising properties, there is 
renewed interest in their inexpensive and flexible manufacture. Flame reactors are 
routinely used to manufacture more than 90% in volume and value of nanoscale 
commodities today [214]. As a result, they have high potential for making a spectrum of 
oxide nanoparticles. In this thesis we designed a laboratory scale coflow flame synthesis 
setup to synthesize iron oxide nanoparticles with controlled size and morphology. We 
now suggest as a future work to investigate progress scale-up. Specifically iron oxide 
nanoparticle synthesis in several diffusion flame reactors of increasing size should be 
systematically studied. These reactors should be operated at the same precursor and fuel 
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flow rates over a range of oxidizer flow rates. For each of the reactors covering the 
turbulent and laminar regimes, a single operation line relating the average product 
particle diameter to burner outlet conditions should be developed for the three reactors 
covering the laminar and turbulent flame regimes. Based on this, process scale-up and an 
operation diagram can be developed for the iron oxide nanoparticle synthesis in coflow 
diffusion flames. 
 
5.2.2 Cellular Uptake and Toxicity Studies 
In this thesis, we showed that flame synthesized nanoparticles are equally 
biocompatible as commercially available ones. However, biocompatible coatings may 
reduce nanoparticle toxic effects and further surface functionalization with bioactive 
factors would make them ideal candidates for several biomedical applications [4].  For 
this reason, as a future work we suggest studying possible methods to coat and 
functionalize nanoparticle surfaces. 
 We also showed that reactive oxygen species formation and actin cytoskeleton 
disruption are two mechanisms working in a coupled manner for nanoparticle toxicity. 
However further studies should be performed to investigate whether nanoparticle uptake 
changes cellular response to biological stimuli. Considering that endothelial cells line the 
inner blood vessel surface, one stimulus is blood flow and the resultant shear stress. As 
future work we suggest investigating changes in cell shear stress response when cells are 
loaded with iron oxide nanoparticles. Below you can find our detailed plan of action to 
address these two topics.  
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5.2.2.1 Functionalization of Nanoparticle Surfaces for Biological Applications 
Suggested future work includes coating and functionalizing nanoparticle surfaces 
for biological applications, including specific cell targeting and bioactive factor delivery. 
As previously mentioned, iron oxide nanoparticles can be conjugated to bioactive factors 
by chemical coupling methods via amide or ester bonds [4]. We suggest using linker 
molecules, including 1-ethyl-3-(3-dimethylaminopropyl) carbodi-imide hydrochloride 
(EDCI), N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP), or N-
hydroxysuccinimide to attach targeting ligands and proteins to nanoparticle surfaces. 
Then nanoparticle endothelial cell toxicity can be assessed using the toxicity assays used 
in this thesis and results can be compared to bare iron oxide nanoparticles. Also the 
nanoparticle effects on the cellular cytoskeleton, specifically actin fiber elongation and 
ROS formation should be investigated. It is expected that when nanoparticles are coated 
with biocompatible coatings it would be possible to increase the nanoparticle dose used 
in the system. It is also expected that these nanoparticles will lead to less defects in the 
cellular cytoskeleton and a decrease in ROS formation. Also by using these 
functionalized nanoparticles in the hybrid nano-biofabrication system, it would be 
possible to initially pattern the bioactive factors in the scaffold and then move them 
during tissue growth while at the same time tracking them. This technique could, for 
example, provide endothelial cells with a changing growth factor gradient to promote 
angiogenesis.  
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5.2.2.2 Magnetically Labeled Cell Response to Shear Stress 
We further suggest studying the effect of nanoparticle-induced actin cytoskeleton 
disruption under mechanical stimuli. We performed preliminary studies investigating 
magnetically labeled cell behavior under applied shear stress conditions. Endothelial cell 
elongation and alignment in the fluid flow direction was first reported in 1972 by 
Flaherty et al. [215] and in vitro in the 1980’s by Dewey et al. [216].  The response was 
found to be related to shear stress changes, as the cells would accommodate the shear 
stress quickly and return to basal morphology in static conditions[217]. The fluid flow 
effect was further shown to depend on shear stress intensity [218, 219]. These studies 
were all under laminar shear stress in an in vitro setting, but endothelial cell elongation 
and alignment has also been observed in vivo [220, 221].  The changes are also seen in 
the internal cell structures, namely the cytoskeleton and the actin filaments.  Early actin 
fiber studies showed that they also aligned in the fluid shear stress direction [222-225].   
We used a rectangular parallel plate flow chamber (GlycoTech Corporation) 
designed for use with a microscope slide for investigating cellular response to shear 
stress.  The flow was controlled with an Ismatec Reglo Digital (Cole Parmer) peristaltic 
pump with a combination of PharMed BPT (Cole Parmer) and platinum cured silicone 
tubing (HelixMark) with a 1.5875 mm inner diameter.  To prevent bubbles from passing 
through the parallel plate and disturbing the cells, a Stovall Flow Cell bubble trap was 
used (Fisher Scientific).  All system parts were thoroughly cleaned before using with 
cells.  The bubble trap and parallel plate were cleaned with 70% ethanol and left to dry in 
sterile environments, while the tubing and glass slides were autoclaved.  The system 
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pulled medium through the bubble trap and parallel plate to help reduce unsteady flow 
from the peristaltic pump (Figure 38).  The eight roller pump also helped reduce flow 
pulsatility.  
 
 
 
 
Figure 38. Parallel plate flow chamber setup with all components and the flow direction 
indicated (Image courtesy Steve Kemeny). 
 
 
 
 
The entire system was run at 37ºC and 5% CO2 in an incubator (Figure 39). Often two 
channels were used at the same time to reduce variation in experimental conditions. 
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Figure 39. Flow test of two parallel plate flow chambers in progress in the incubator to 
maintain temperature and pH.  
 
 
 
 
When endothelial cells were exposed to the 20 dynes/cm2 shear stress for 24 hours, they 
elongated and aligned in the flow direction while cells not exposed to flow maintained 
their polygonal shape. The actin labeled cells with or without nanoparticles showed fibers 
aligning the flow direction (Figure 40). 
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Figure 40. Images of actin filaments in cells under flow (A) static, 24 hours of flow at 20 
dynes/cm2 on cells not loaded with nanoparticles (C) cells loaded with 0.5 mg/ml of iron 
oxide nanoparticles. Scale bar is 30µm. 
 
 
 
 
The angle distribution plot in Figure 41 showed magnetically labeled cells aligned more 
to the shear stress than the control cells.  The fiber angle distribution standard deviation 
for static culture with nanoparticles is 52.2° ± 3.2° and without nanoparticles is 48.91° ± 
1.1°. Then after 24 hours of shear stress exposure, the angle distribution standard 
deviation for the cells loaded with nanoparticles was 32.1° ± 3.0° while it was 43.3° ± 
3.1° for cells without nanoparticles. Keeping in mind that lower standard deviations mean 
more aligned cells, the cells with nanoparticles appeared to align more to the flow 
direction (p = 0.0305).   
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Figure 41. Cells loaded with nanoparticles aligned more to the 20dynes/cm2 shear stress. 
The standard deviation of the angle distribution for the cells loaded with nanoparticles 
was 32.1° ± 3.0° while it is 43.3° ± 3.1° for cells without nanoparticles (p=0.0305).  
 
 
 
 
These studies suggest that nanoparticle exposure changes cell response to 
mechanical stimuli, in this case shear stress. However these results are preliminary and 
should be repeated with different nanoparticle concentrations. Also a time study can also 
be performed whether nanoparticle uptake delays or accelerates cell response to flow. For 
the same nanoparticle concentrations, ROS levels in the cells should also be measured 
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after 24 hours exposure to the shear stress, and the relationship between ROS formation 
and actin cytoskeleton alignment should be investigated.  
 
5.2.3 Bioprinted Nanoparticles for Tissue Engineering Applications 
In this thesis, we showed that a decrease in cellular viability is observed when 
cells were loaded with iron oxide nanoparticles and printed with the hybrid printing 
system. We increased the viability to some extent by decreasing the printing pressure 
however printing of tissue scaffolds with lower printing pressure might not be an efficient 
method for manufacturing since it slows down the process. For this reason, as future 
work, we suggest improving printed magnetically labeled cell viability by exploring 
different nanoparticle sizes and shapes, as well as attaching nanoparticles to the cell 
membrane. Bioactive factor conjugated nanoparticles can be printed with the hybrid 
system which would give us the ability to precisely pattern cells and bioactive factors 
throughout the tissue growth process and this will improve fabrication of complex 
tissues. We also observed that cells do not attach to alginate scaffolds which results in a 
decrease in cellular function and affects cell proliferation. We suggest using collagen gels 
with a cooled printing system. We also observed some difficulties in the nanoparticle or 
cell pattern movement inside the tissue scaffolds when patterns were complex shapes. To 
solve this problem, we suggest using complex magnet arrangements to control cell 
movement and patterning after printing in the tissue engineered construct. 
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5.3 Advancing Engineering Knowledge 
Nanoparticles are an expected future manufacturing material that will make most 
products lighter, stronger, cleaner, less expensive and more precise. But as captivating as 
this technology may seem, numerous technological and market hurdles to 
commercialization exist. Nanoparticles can be used in industry only with a keen 
understanding of the basic science as applied to actual production requirements and 
market needs. Especially, current liquid phase synthesis methods produce low 
nanoparticle quantities. New techniques are needed to develop industrial viable processes 
which manufacture nanoparticles at high quality and large volumes. In previous research, 
flame operating conditions like flame temperature and configuration were shown to effect 
final TiO2 and SiO2 nanoparticle morphology and chemistry [135]. This thesis showed 
that iron oxide nanoparticle morphology and chemistry can also be controlled by 
changing flame operating conditions. These data demonstrate that critical synthesis 
parameters for TiO2 and SiO2 metal nanoparticles are also valid for iron oxide synthesis, 
suggesting that it might be possible to control characteristic properties of the other metal 
oxide nanoparticles using flame synthesis conditions as well. Additives have also 
previously been used to create composite metal oxide structures, such as silica coated 
iron oxide synthesized by Zachariah [46]. However our studies revealed that additives 
sometimes do not form composite structures but rather change the core synthesized metal 
oxide morphology while creating a heterogeneous mixture of two separate metal oxides. 
This implies that using additives to form composite structures should be investigated 
more carefully to avoid unwanted changes in final nanoparticle morphology. 
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We can use nanotechnology in medicine only if we can make sure that 
nanoparticles are not toxic to the human body. We demonstrated that as long as 
nanoparticle size, composition and shape are the same, the nanoparticle synthesis method 
does not affect cytotoxicity. This suggests that the cheapest method to produce the most 
accurate nanoparticles, such as flame synthesis for metal oxide nanoparticles, should be 
used. This thesis additionally made significant process towards understanding 
nanoparticle toxicity mechanisms. We showed that reactive oxygen species formation 
and actin cytoskeleton disruption are the two mechanisms playing a major role in cell 
toxicity. ROS formation has been observed with other nanoparticles types and other cell 
lines. This thesis, by proving that ROS are a primary cytotoxicity mechanism for iron 
oxide nanoparticles and endothelial cells, further suggests that ROS generation may be a 
general mechanism for the nanoparticle cytotoxicity. We also demonstrated ROS 
blockade prevented actin cytoskeleton disruption and cell death to some extent. This 
finding might enable safer use of nanoparticles in medicine. If reactive species formation 
could be restricted after the cellular nanoparticle uptake, either by conjugating ROS 
blockers to the nanoparticles or by giving systemic ROS blockers before the nanoparticle 
application, it might be possible to reduce nanoparticle toxic side effects in the human 
body. In this way, higher nanoparticle doses could be used in various medical 
applications. Our data also suggest that ROS generated after nanoparticle uptake might 
also affect cell structure, cell response to mechanical stimuli, and several other key cell 
functions like cellular motion, intracellular transport and cellular division which depend 
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on the cell cytoskeleton. Scientists working with nanoparticles should also focus on 
functional changes in magnetically labeled cells in addition to cytotoxicity. 
Due to the accidents, birth defects and diseases, a large number of people around 
the world suffer organ and tissue loss every year. Novel technologies must be developed 
to enable tissue engineering of complex organs. The novel hybrid solid freeform 
fabrication system enabled the fabrication of functionalized tissue scaffolds as well as 
movement of cells and bioactive factors inside the tissue constructs. This expands the 
capabilities of the field by making tissue engineering an active process during 
development. Tissue engineers can potentially control tissue constructs after the construct 
design and initial fabrication. The designed hybrid system will also make it possible to 
noninvasively track the cell movement inside the constructs, which could dramatically 
enhance our understanding of tissue development. The hybrid solid freeform fabrication 
system has applications beyond tissue engineering. This technique will also advance 
general solid freeform fabrication techniques for all-purpose manufacturing operations 
since it enables layer by layer manufacture of three dimensional shapes of polymers 
mixed with nanoparticles without losing the quality and geometric precision of the final 
product. The decrease observed in the cell viability in magnetically labeled cells after 
bioprinting revealed that cells may be more sensitive to mechanical forces when they are 
loaded with nanoparticles. This should direct nanoparticle toxicity studies to changes in 
cell response to mechanical stimuli when loaded with nanoparticles. Also we showed that 
bioprinting effects on overall cell viability are cell type specific and for each cell line 
should be investigated separately. 
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Overall, this thesis provided valuable insight into the synthesis of iron oxide 
nanoparticles, underlying toxicity mechanisms leading to cellular dysfunction and cell 
death and finally provided a unique tool to manufacture and noninvasively image three 
dimensional tissue constructs by using principles of nanotechnology to advance the field 
of tissue engineering. As this work continues, I hope these discoveries will be further 
developed and used in medical therapies to ameliorate human disease.  
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